The biological importance of apurinic/apyrimidinic endonucleases in the maintenance of genetic stability by Vongsamphanh, Ratsavarinh
Université de Montréal
The biological importance of apurinic/apyrimidinic endonucleases in
the maintenance of genetic stability
par
Ratsavarinh Vongsamphanh
C
Département de microbiologie et immunologie
faculté de médecine
Thèse présentée à la Faculté des études supérieures
en vue de l’obtention du grade de philosophiae doctor (Ph.D)
en microbiologie et immunologie
Octobre 2006
O © Ratsavarinh Vongsamphanh 2006
“iiq
Q
Université (JI
de Montréal
Direction des biblïotlièques
AVIS
L’auteur a autorisé l’Université de Montréal à reproduire et diffuser, en totalité
ou en partie, pat quelque moyen que ce soit et sur quelque support que ce
soit, et exclusivement à des flns non lucratives d’enseignement et de
recherche, des copies de ce mémoire ou de cette thèse.
L’auteur et les coauteurs le cas échéant conservent la propriété du droit
d’auteur et des droits moraux qui protègent ce document. Ni la thèse ou le
mémoire, ni des extraits substantiels de ce document, ne doivent être
imprimés ou autrement reproduits sans l’autorisation de l’auteur.
Afin de se conformer à la Loi canadienne sur la protection des
renseignements personnels, quelques formulaires secondaires, coordonnées
ou signatures intégrées au texte ont pu être enlevés de ce document. Bien
que cela ait pu affecter la pagination, il n’y a aucun contenu manquant.
NOTICE
The author of this thesis or dissertation has granted a nonexclusive license
aNowing Université de Montréal to reproduce and publish the document, in
part or in whole, and in any format, solely for noncommercial educational and
research purposes.
The author and co-authors if applicable retain copyright ownership and moral
rights in this document. Neither the whole thesis or dissertation, nor
substantial extracts from it, may be printed or otherwise reproduced without
the author’s permission.
In compliance with the Canadian Privacy Act some supporting forms, contact
information or signatures may have been removed from the document. While
this may affect the document page count, it does flot represent any loss of
content from the document.
Université de Montréal
Faculté des études supérieures
Cette thèse intitulée:
The biological importance of apurinic/apyrimidinic endonucteases in
the maintenance of genetic stability
présentée par:
RATSAVARINH VONGSAMPHANH
o
a été évaluée par un jury composé des personnes suivantes:
Dr. Elliot Drobetsky
président-rapporteur
Dr. Dindial Ramotar
directeur de recherche
Dr. Janos Filep
membre du jury
Dr. Daniel Durocher
examinateur externe
Dr. Jean-François Côté
représentant du doyen de la FES
C
111
RÉSUMÉ
Les dérivés réactifs de l’oxygène produisent de multiples lésions à l’ADN,
notamment des sites abasiques (AP). Les dommages oxydatifs de l’ADN sont réparés
principalement via la voie de réparation par excision de bases dans laquelle les AP
endonucléases jouent un rôle crucial. Les cellules déficientes pour les AP
endonucléases sont hypersensibles aux agents aikylants (e.g. MIVIS) et oxydants (e.g.
H202). Nous sommes intéressés par l’étude moléculaire des AP endonucléases
eucaryotiques afin de mieux comprendre leurs mécanismes enzymatiques. Notre
première étude porte sur la structure et la fonction de la principale AP endonucléase
de la levure $accharornyces cerevisiae, Apnl. Nos résultats démontrent clairement
l’importance des acides aminés G1u15$ et Asp192 pour l’activité biologique d’Apnl,
étant donné qu’une mutation d’un de ces résidus abolit significativement son activité
enzymatique. Lors de notre deuxième étude, nous avons évalué le rôle de l’ADN
glycosylase Oggi de la levure dans l’instabilité des séquences poly(GT)
mitochondriales. Nous avons observé qu’une surproduction d’Apnl cause une
( augmentation de l’instabilité des séquences poly(GT). Cet effet fût toutefois
contrebalancé par la surexpression d’ Ogg 1. Nos résultats indiquent que la protéine
Oggl compétiolme avec Apnl possiblement pour la liaison des sites AP afin
d’empêcher la réparation incontrôlée par Apnl. Notre troisième étude avait comme
but initial l’identification de l’homologue humain d’endo IV. Cependant, nous avons
isolé l’enzyme glycolytique, GAPDH. Nos résultats démontrent que GAPDH
interagit avec APEÏ afin de stimuler son activité AP endonucléase en convertissant la
forme oxydée d’APEl en sa forme réduite. De plus, les résidus Cys 152 et Cys156 de
GAPDH sont importants pour la stimulation de APE1. Le rôle que joue GAPDH dans
la résistance cellulaire face aux agents génotoxiques, tels le MMS et H202, fût
également démontré par des tests de viabilité cellulaire. Collectivement, nos études
confirment l’importance biologique des AP endonucléases dans la réparation des sites
AP. De plus, elles ont permis de comprendre davantage les mécanismes par lesquels
ces enzymes contribuent à la stabilité génétique dans la celltile.
Mots-clés : dommage oxyc1atfà 1 ‘ADÀ’ réparation par excision de bases, interaction
( protéique, modUication posttransÏationneÏle.
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ABSTRACT
Living organisms are constantly exposed to reactive oxygen species which are
known to cause a variety of DNA lesions, such as apurinic/apyrirnidinic (AP) sites.
The repair of oxidative DNA damage is primarily mediated by the base excision
repair (BER) pathway. AP endonucleases are key enzymes in this process. Celis
deficient in AP endonucleases are hypersensitive to aikylating (e.g. MMS) and
oxidizing (e.g. 11202) agents. We are interested in studying eukaryotic AP
endonucleases at the molecular level to gain insights into their mechanisms of DNA
binding and cleavage at AP sites. n our first study, we carried out the first
structure/fttnction analysis of Apnl, the major AP endonuclease in yeast
Saccharornyces cerevisiae. Our data indicate that two conserved amino acids residues
of Apnl, G1u15$ and Asp192, are critical for its biological function, since glycine
substitutions at these positions abolished its DNA repair activities. In our second
study, where we evaluated the role of yeast Oggi DNA glycosylase in the
maintenance of a mitochondrial poly(GT) tract reporter system. we discovered that
overproduction of Apnl causes instability of the poly(GT) tracts. Interestingly, this
effect was counteracted by overexpression of Oggi. Our results clearly suggest that
uncontrolled DNA cleavage by Apnl is prevented by Oggi which most likely
competes with Apnl for binding to AP sites. In our final study, we set out to identify
the endo IV homolog in human ceils, but we unexpectedly re-isolated GAPDH, a
classical glycolytic enzyme. We demonstrated that GAPDH interacts with APE1 to
stimulate the AP endonuclease activity by converting the oxidized forms of APE 1 to
the reduced forms. Futhermore, we also showed that Cys 152 and Cysi 56 of GAPDH
are important for APE1 reactivation. Consistent with this notion, we demonstrated
that GAPDH plays an important role in the cellular resistance against genotoxic
agents such as MMS and H202 by cell survival assays. Taken together, our studies
reinforce the biological significance of eukaryotic AP endonucleases in the repair of
AP sites, but more irnportantly, they provide valuable insights into the rnechanisms
by which AP endonucleases maintain genomic stability in the cell.
Keywords: oxidative DNA damage, base excision repair, protein interaction,
posttranslationaÏ modlification.
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Miss Vongsamphanh evaluated the effect of DNA repair proteins on the rate
of the poly(GT) tract instability in the mitochondrial genome by calculating the rate
of the Arg revertants in various strains containing certain vector or plasmid (Table
III—I).
(3) Jilani, A., Vongsamphanh, R., Azam, S., and Ramotar, D. (2006) Human
GAPDH functions as a redox factor to reactivate the oxidized form of the DNA
repair enzyme APE1. In preparation (Chapter 4).
Arshad Jilani made the following constructs which were used in this study:
pHIS-APE! and pGST-GAPDH. He then used the latter plasmid as the template for
glycine substitution at positions C152, C156, and C247 by site-directed mutagenesis
to produce the plasmids pGST-GAPDH C152G, pGST-GAPDH C156G, pGST
GAPDH C247G, respectively.
Dr. Jilani cultured LF 1 human lung fibroblasts. He prepared the ccli extracts
ç
and subjected them to a six-step coiumn chromatography purification to enrich for a
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Mg2-independent AP endonuclease activity. He analyzed the six eluted fractions
from the final step of purification by SDS-PAGE gel stained with Coomassie blue
(Figure 4-lA) and by AP endonuclease assay (Figure 4-13). Ratsavarinh
Vongsamphanh measured the AP endonuclease activity of the purified polypeptide
(Figure 4-ÏC). Protein sequencing by LC-MS. which was done by Harvard’s
Microchemistry Facillty, revealed that the purified protein is GAPDH.
Both Mr. Jilani and Miss Vongsamphanh purified the following fusion
proteins: GST-GAPDH, GST-GAPDH C152G, GST-GAPDH C156G, G$T-GAPDH
C247G, and HIS-APE1. Ail the purified fusion proteins were used in our in vitro
studies. Ratsavarinh Vongsamphanh measured GAPDH glycolytic activity of the
purified polypeptide, the various purified GST-GAPDH fusion proteins as well as the
the commercial preparations of GAPDH (Figure 4-2A). Dr. Jilani analyzed the
expression level ofthe purified GST-GAPDH by Coornassie blue stained SDS-PAGE
gel (Figure 4-2B).
The interaction between GAPDH and APE1 was detected by HIS-APE1
( affinity columns (done by Arshad Jilani; Figure 4-3A), and by GST pull-down assays
and by immunoprecipitation experiments (both done by Ratsavarinh Vongsamphanh;
Figure 4-33 and C, respectively). Arshad and Ratsavarinh performed an AP
endonuclease assay on commercial preparations of GAPDH from various organisms
(Figure 4-3D).
Both Dr. Jilani and Miss Vongsamphanh measured the effect of increasing
concentrations of purified GST-GAPDH on a fixed amount of purified HIS-APE1.
They found that GAPDH stimulated APE 1 AP endonuclease activity in a dose
dependent manner (Figure 4-4).
Mr. Jilani and Ratsavarinh analyzed the effect of GST-GAPDH on the redox
status of the reduced and oxidized HIS-APE1 by SDS-PAGE gel stained with silver
stain (Figure 4-5A and data not shown). Both Arshad and Ratsavarinh verify the
effect of GAPDH on the AP endonuclease activity of oxidized APE1 (Figure 4-5B).
Ratsavarinh tested if other reducing agents (e.g. DTT, glutathione, and NAC),
magnesium, or DTT pre-soaked APE1 can also stimulate oxidized APEI (data not
( shown).
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Dr. Jilani did the AP endonuclease assay with the various GAPDH mutants
(Figure 4-6). The mutants GAPDH C152G and GAPDH C156G are unabic to
stimulate APE1 AP endonuclease activity. Miss Vongsamphanh demonstrated by an
AP endonuclease assay that only reduced GAPDH can stimulated oxidized APE1
(data not shown).
Miss Vongsamphanh cultured the DLD-1 celi une stab!y transfected with
either pGFP or pGFP-GAPDH pÏasmid. She measured ce!! survival by clonogenic
assay following MMS, F1202, and UVC treatment (Figure 4-7A).
Sonish Azam did the siRNA knockdown of GAPDH in HCT1 16 by
tranfection. Dr Azam ana!yzed the effectiveness of the siRNA treatment by Western
Mot (Figure 4-7B) and she performed the clonogenic assay afier MMS and UVC
treatments (figure 4-7C).
(CHAPTER 1
GENERAL INTRODUCTION
o
C
2OXIDATIVE DNA DAMAGE
Living organisms are constantly exposed to potentially harmful reactive
oxygen species (ROS). One of the cellular targets for oxidative damage by ROS is
DNA [1]. failure to repair oxidative DNA lesions may lead to mutagenesis.
carcinogenesis, and aging [2].
Generation and detoxificatïon of reactive oxygen species
ROS such as hydrogen peroxide (11202), superoxide anions (02) and
hydroxyl radicals (0H) are generated through both endogenous and exogenous
sources including oxidative electron transport chain in the mitochondria, pathological
processes such as infection and inflammation, rnetabolism of exogenous compounds
(e.g. paraquat), cigarette smoke, ultraviolet (UV) light, and ionizing radiation [3-5].
Amongst ail the oxygen radicals, the 0H is the most reactive towards biological
molecules [6].
To prevent the negative effects of ROS, aerobic organisrns have evolved
numerous defense mechanisms which scavenge and inactivate ROS. The simplest
defense mechanism consists of several low molecular weight nonenzyrnatic
antioxidants that include vitamins C and E, glutathione, and thioredoxin [7]. The
other, more complex, defense mechanism impiicates the activation of enzymes, such
as glutathione peroxidase, superoxide dismutase, and catalase [8,9]. Low levels of
ROS can escape these natural cellular defense systems, thus, resulting in a tolerable
background level of damage. If the production of ROS however overwhelms the
cellular detoxification mechanisms, oxidative stress is the resuit [10]. This condition
causes an accumulation of oxidative damage to biomolecules such as lipids. proteins,
and DNA [5]. Since proteins and lipids are readily degraded and resynthesized, the
most significant consequence of oxidative stress is thought to be DNA damage,
specifically, to its base and sugar moieties [11,12].
C
3Types of oxidative DNA lesions
Base damage
More than 70 different types of base damage have been identified in DNA
following exposure to oxidative stress, thus forming the major class of ROS-induced
DNA lesions [7]. The chemical structures ofthe major oxidative DNA base damages
are shown in Figure 1-1. The C5=C6 double bond of pyrimidines is particularly
sensitive to an attack by 0H, generating a variety of oxidative pyrimidine lesions,
including thymine glycol (Tg), uracil glycol, 5-hydroxy-dU, and 5-hydroxy-dC [13-
15]. Similarly, the C4-, C5- and Cg-position of purines are highly susceptible to an
addition of 0H, producing mainly 8-oxo-dGuo, 8-oxo-dA, and
formamidopyrimidines [7]. 1g and 8-oxo-dGuo are representative of oxidized
pyrimidines and purines, respectively (insets in Figure 1-1). The biological
consequences of many oxidative base lesions have been studied extensively. for
example, unrepaired 1g is cytotoxic as it block DNA replication, whereas 8-oxo-
dGuo is highly mutagenic since it readily bypassed by DNA polymerases [1,16-18].
Unrepaired 8-oxo-dGuo frequently mispairs with adenine during DNA replication,
thereby generating GC to 1A transversion mutations [17,18].
Sztgar damage
In addition to the base residue, 0H also targets the sugar moiety of DNA,
resulting in the abstraction of hydrogen atoms from carbon atoms of the deoxyribose
residue [71. The oxidized carbon can undergo additional reactions, depending on the
availability of molecular 02, thus producing several sugar modifications, including
single-strand breaks (ssb) and a variety of apurinic/apyrimidinic (AP) sites (Figure I -
2) [7]. AP sites are also formed spontaneously at a substantial rate due to the lost of
purine bases. [19] It lias been estimated that at Ieast 10 000 depurination events occur
in a single mammalian ce!! per day, thus making AP sites one of the most frequent
lesions in DNA [20]. Sugar modifications, such as ssb, may act as an
C
4Figure 1-1. Cliemical structures ofthe major oxidative UNA base lesions.
The representative of oxidized pyrimidines and purines: thymine glycol (1g) and 8-
oxo-deoxyguanosine (8-oxo-dGuo), respectively, are shown in the insets.
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$inhibitor of DNA replication, and are thus toxic to celis [7]. On the other hand,
unrepaired AP sites can resuit in a block to DNA replication, cytotoxicity, and
mutations [20].
Thus, to prevent such harmful outcomes of the numerous DNA base and sugar
lesions, ail organisms have evoÏved several DNA repair mechanisms to ensure proper
removal of oxidative DNA damages.
REPAIR 0f OXIDATIVE DNA DAMAGE
The highly conserved base excision repair (BER) pathway is believed to be
the primary defense mechanism against oxidative DNA base damage induced by ROS
or simple aikylating agents, such as methyl methane sulfonate (MM$) [21].
Base excision repair
The multi-step BER process involves the concerted action of several proteins
that recognize, excise, and repair an oxidative DNA base lesion, ultimately replacing
the damaged moiety with the correct nucleotide (figure 1-3 and Table I-I) [22,23].
BER is initiated by a DNA glycosylase that cleaves the N-glycosilic bond between
the damaged base and DNA sugar phosphate backbone [24,25]. DNA glycosylases
are divided into two groups: monofunctional and bifunctional DNA glycosylases
[26,27]. Monoftmctional glycosylases possess only base excision activity (Figure 1-3,
depicted to the left), whereas bifunctional glycosylases act both to excise a damaged
base and to incise 3’ at the resulting AP site with their associated AP lyase activity,
yielding a strand break with a 3’-blocking group and a normal 5’-phosphate residue
(Figure 1-3, depicted to the right) [26,27]. for monofunctional glycosylases, the
resulting AP site is cleaved at its 5’ by an AP endonuclease, leaving behind a strand
break with a normal 3’-OH group and an abnormal 5’-deoxyribose-5-phosphate
(dRP) fragment (Figure 1-3, middle). In either case, the abnormal 3’-blocking group
and 5’-dRP residue, produced by an AP lyase and AP endonuclease activity,
respectively, must be processed prior to repair completion. The 3’-blocking group is
excised by an AP endonuclease-associated 3’-phosphodiesterase activity, while the
C
o9
Figure 1-3. Schematic representation of the base excision repair (BER) pathway.
Shown is a general model of the short-patch (right) and the long-patch (lefi) BER
pathways, and the enzymes to be involved in the individual steps. $ee main text for
additional details.
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Table I-I. Summary of the principal BER enzymes in Escherichia cou,
Saccharornyces cerevisiae, and human.
E. cou S. cerevisiae Human Repair activity
ung UNG UDG Uracil DNA glycosylase
aÏkA MAG MPGIAAG Methylpurine DNA glycosylase
-
- TDG Thymine DNA glycosylase; excises T
opposite G
nth NTGJ, 2 NTH] Oxidized pyrimidine (Tg) DNA glycosylase;
AP lyase
nei - NEIL], 2 Oxidized pyrimidine DNA glycosylase; AP
f3,1yase
fpg OGG], 2 OGGJ 8-oxo-dGuo DNA glycosylase; AP lyase
mutY - MYH Adenine DNA glycosylase; excises A
opposite $-oxo-dGuo
rnutT - MTH $-oxo-dGuo triphosphatase
xth - APE] AP endonuclease; 3’-repair diesterase; 3’-
exonuclease
APN2 APE2 3’-5’ exonuclease; 3’-repair diesterase; AP
endonuclease
nfo APNJ Absent to AP endonuclease; 3’-repair diesteraseQ datepolI RAD27 FEN] flap endonuclease; functions in long-patch
BER
POLX POL/3 Gap-filling DNA polymerase (in the
nucleus); dRP lyase
POL2, 3 FOL Replicative DNA polymerases
MIP] POLG Gap-fihling DNA polymerase (in the
mitonchondria); dRP lyase
poli11 (f3- POL3O PCNA Siiding clamp for DNA polymerase fiand
subunit c; stimulates FEN activity, as well as other
long-patch BER activities
poli11 (y- CDC44 RFC PCNA loading factor
complex)
ligA CDC9 LIG], 3 Nick ligase; LIG1 functions in short- and
long-patch BER, whereas LIG3 acts mainly
in short-patch BER
- XRCC] Scaffold protein (no known enzymatic
activity)
o
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transient 5’-dRP residue is removed by DNA polymerase fi (Pol /J)-associated 5’-
deoxyribose-5-phosphodiesterase (dRPase) activity. Then, Pol fi inserts the correct
nucleotide, and a DNA ligase seals the nick, thereby, repairing the damage [2$]. The
repair pathway described above is named short-patch BER (Figure 1-3, pathway on
the right).
An alternative BER pathway
In mammals, an alternative BER pathway exists, termed the long-patch
pathway which involves the replacement of approximately 2 to 10 nucleotides,
including the damaged base (Figure 1-3, pathway on the lefi) [29]. In addition to the
protein described for the short-patch pathway, the long-patch BER involves the
replicative enzymes Pol c5 and the accessory factors PCNA (proliferating ccli
nuclear antigen) and RF-C (replication factor-C), as well as the endonuclease FEN1
(flap endonuclease 1) [30,31]. Either Pol fi or Pol &, with the assistance of PCNA
and RF-C, carnes out strand-displacement synthesis to replace the missing
nucleotides [30,31]. The resulting flap structure containing the 5’-dRP residue is
subsequently removed by the flap endonuclease activity of FEN1, and the remaining
nick is then sealed by DNA ligase I [30,31]. Studies have shown that both the fission
yeast Schizosaccharomyces pombe (S. pombe) [32] and the budding yeast
Saccharomyces cerevisiae (S. cerevisiae) have homologues to mammalian FEN 1,
PCNA, and RF-C [26]. However, the existence of the long-patch repair pathway lias
been confirmed only in S. pombe [32].
Potential mechanisms of switching between BER subpathways
The short-patch BER predominates over the long-patch pathway in mammals,
yet the precise mechanism that controls the switching between these two pathways
remains undetermined [33,34]. Previous reports have postulated that the type ofDNA
lesions and the nature of DNA glycosylases involved constituted the major
determinants in the choice of the BER subpathway. Base lesions (e.g. $-oxo-dGuo
and Tg) that are excised by bifunctional giysosylases (e.g. OGG1 and NTHÏ) were
shown to trigger mainly the short-patch repair since the 5’-phosphate residue
13
produced afier AP lyase incision prevents strand dispiacement by Pol ,B (Figure 1-3,
pathway on the right) [35]. In contrast, both the short- and long-patch BER
subpathways are activated when monoftmctional glycosyalses (e.g. UDG) initiate
repair of damaged bases, such as uracil [35J. Recently, Petermaim et aï. however
provided strong evidence for a key role of the Ligase III/XRCC 1 complex in
regulating the switching between the BER subpathways [36]. They demonstrated that
the short-patch subpathway predominates when ATP-dependent ligation of the nick
containing 5’-dRP residue takes place. Conversely, when ligation is inhibited due to
ATP shortage and/or mutations in Lig III, XRCC 1 stirnulates Pol fl-dependent DNA
synthesis of a multi-nucleotide patch, thus resulting in the activation of the long-patch
BER subpathway. Consistent with this notion, the authors showed that the long-patch
repair prevails over the short-patch subpathway in HeLa celis knockdowned for the
Lig III!XRCC1 complex [36].
Association between BER defects and human cancer
Genetic polyrnoiphisrns
Many highly prevalent single-nucleotide polymorphisms have been found in
several BER genes, such as OGG1, APE1, Pol fland XRCCI [37]. However, to date,
no human diseases have been directly connected to their defects. Various case-control
studies have investigated the association between the genetic variants of OGG1
(Ser326Cys), APE1 (Aspl4$Glu), Pol /3 (Lys289Met and Ile26OMet), and XRCC1
(Argl94Trp, Arg28OHis, and Arg399Gln) and cancer risk [37]. However, these
epidemiological investigations have yet to clearly demonstrate a direct effect of these
polymorphisms on cancer susceptibility. For example, the Ser326Cys polymorphism
ofOGGi lias inconsistently been associated with risk of lung cancer [37]. Out offive
studies which analyzed the homozygous mutant alleles, two were statistically
significant whereas two studies showed no interaction [37]. Similarly, resuits of
frmnctional studies on the Ser326Cys OGGY variant are also inconclusive. Some
studies suggest reduced repair activity with the Ser326Cys variant, whereas others did
flot find an association between the Ser326Cys polymorphism in cancer and DNA
repair capacity [37]. Thus, larger epidemiologic and functional studies are needed to
14
clearly establish a reÏationship between cancer and these genetic variants of BER
genes.
However, Al-Tassan and colleagues have demonstrated that inherited defects
of the adenine DNA glycosylase MYH is associated with somatic GC to TA
tranversion mutations in the adenornatous polyposis cou (APC) gene, which is
normally linked to familial adenomatous polyposis, a type of hereditary colon cancer
[38]. MYH is thus the flrst BER gene associated with a human cancer syndrome.
Mouse models
Over the iast decade, several BER-deficient mouse models have been
generated to study the relationship between BER dysftinction and carcinogenesis
[39]. A surnmary of the BER mouse models, and their related phenotypes, is
delineated in Table I-II. At first glance, it is evident that the next generation ofmouse
modeis should comprised of combined deficiencies of DNA glycosylases which
initiate the BER pathway as weII as ofconditionai modeis ofthe intermediate and late
steps of BER before a direct link can be established between BER deficiency and
cancer.
AP ENDONUCLEASES
In addition to being central damage intermediates in BER, AP sites are
considered to 5e one ofthe most frequent endogenous lesions in DNA [19,40]. Due to
their mutagenic and cytotoxic properties, the repair of AP sites is essential to ensure
genome stability and ccli survivai [41]. AP sites can 5e processed either by AP
endonucleases or glycosylases/AP iyases (figure 1-3). StiIl, The 3’-blocking groups
produced following incision by glycosylases/AP lyases must be further processed to
produce an accessible 3’-OH termini required for repair synthesis by DNA
polymerases [1]. The majority of the celiular 3’-phosphodiesterase activity is
provided by AP endonucleases (figure 1-3, pathway on the right) [1]. Thus, this class
of enzymes is considered to be far more efficient in repairing AP sites than
glycosylases/AP lyases.
15
Table I-II. Summary of BER mouse models.
Mouse model Relevant phenotype Reference
Oggi Mice are viable [421
Jncreased 8-oxoG level and G to T transversions
Mvii Mice viable [43]
Two-fold increased spontaneous mutation frequency in null
ES cells
Ogg]/M)’h Mice viable [44]
Significantly enhanced tumor incidence
Nth] Mice are viable and exhibit no abnormalities [45]
Increased levels of Tg
Ogg]/Nth] Celis are defective in the repair of oxidized pyrimidines in [46]
mtDNA
Ung Mice are viable and develop normally [47]
Increased incidence of B-cell lymphomas at old age
Aag Mice are viable and develop normally [48,49]
Celis exhibit increased sensitivity to DNA-alkylating agents
Apex] Embryonic lethal at E7.5 [50,51]
Cells from heterozygous mutants are sensitive to oxidizing
agents
Pot fi Embryonic lethal at E 18.5 [52]
Fen] Embryonic lethality at E4.5 [53,54]
Fen mice are normal
XRCC] Embryonic lethal at E8.5 [55]
Lig J Embryonic lethal at E 15.5-16.5 [56]
G
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( Sequence and structural conservation of AP endonucleases
AP endonucleases are evolutionary highly conserved DNA repair enzymes
which are grouped into two distinct families, the exonuclease (exo) III and the
endonuclease (endo) IV families, named afier the Escherichia cou (E. cou) members
[1,57-59]. The exo III family includes E. cou exo III, 8. cerevisiae Apn2,
Caenorhabditis elegans (C. etegans) EXO-3, human APE1 and APE2. The exo III
members are small, monomeric, divalent metal ion-dependent enzymes that are
sensitive to metal-chelating agents, such as EDTA [60-62]. On the other hand, AP
endonucleases of the endo IV family, comprising E. cou endo IV, £ cerevisiae Apnl,
and C. elegans APN- 1, are resistant to inactivation by EDTA since they are metal
ion-independent enzymes [60,63]. Although no homolog of the endo IV family has
yet been identified in human celis, such activity is Iikely to be present in there as well
(See Table I-III for a summaiy ofthe AP endonuclease enzymes).
In addition to their sequence sirnilarity, related AP endonucleases also share
structural homology, as suggested by high-resolution crystal structures for their
representative members. Both E. cou exo III and human APE1 possess a
characteristic four-layered u43-sandwich fold which is also found in the digestive
enzyme DNase I [64,65]. However, their DNA-binding domain loops adopts an
extrahelical conformation that is flot observed for DNase I. These protruding loops
are proposed to be involved in damage recognition and bond cleavage at AP sites
[65]. Recently, Kaneda and colleagues demonstrated by site-directed mutagenesis that
the amino acid residues, Trp-212 and Trp-2$0, near the catalytic site of exo III and
APE 1, respectively, are critical for AP site recognition as well as AP endonuclease
activity [66]. They propose a model whereby the tryptophan residue ofexo III-related
enzymes acts as an AP site ‘recognizer’ by intercalating its aromatic side chain into
the AP site pocket, followed by flipping out of the AP site from the duplex into the
enzyme catalytic pocket with DNA kinking at the AP site [66]. for
©T
a
b
le
I-
II
I.
C
o
m
p
a
ri
so
n
o
f
A
P
e
n
d
o
n
u
c
le
a
se
s
in
b
a
c
te
ri
a
,
y
e
a
st
,
a
n
d
h
u
m
a
n
.
E.
co
ti
S.
ce
re
v
isi
ae
H
u
m
a
n
G
e
n
e
n
a
m
e
P
ro
te
in
n
a
m
e
F
a
m
il
y
n
a
m
e
C
o
fa
c
to
rs
In
h
ib
it
o
rs
L
e
n
g
th
M
o
le
c
u
la
r
w
e
ig
h
t
A
P
e
n
d
o
n
u
c
le
a
se
a
c
ti
v
it
y
3‘
-
p
h
o
sp
h
o
d
ie
st
e
a
se
a
c
ti
v
it
y
3’
-5
’
e
x
o
n
u
c
le
a
se
a
c
ti
v
it
y
N
u
c
le
o
ti
d
e
in
c
is
io
n
a
c
ti
v
it
v
R
e
le
v
a
n
t
m
u
ta
n
t
p
h
e
n
o
tp
e
x
th ex
o
III
Ex
o
UI
M
g2
ED
TA
26
8
aa
30
.9
7
kD
a
90
%
90
%
Ro
bu
st
Sp
ec
ifi
c
fo
r3
’
re
ce
ss
ed
en
ds
o
fD
N
A
A
bs
en
t
H
yp
er
se
ns
iti
ve
to
o
x
id
iz
in
g
ag
en
ts
n
fo
en
do
IV
En
do
IV
n
o
n
o 28
5
aa
31
.4
$ k
D
a
10
%
*
2O
fl
d
in
du
ct
io
n
by
pa
ra
qu
at
10
%
*
2O
fl
d
in
du
ct
io
n
by
pa
ra
qu
at
H
ig
h
Pr
ef
er
en
ce
fo
r
3’
re
ce
ss
ed
su
bs
tra
te
Pr
es
en
t
H
yp
er
se
ns
iti
ve
to
o
x
id
iz
in
g
ag
en
ts
A
PN
I
A
pn
l
En
do
1V
n
o
n
o 36
7
aa
41
.4
4
kD
a
97
%
.
97
%
R
ob
us
t
Pr
ef
er
en
ce
fo
r
3’
re
ce
ss
ed
D
N
A
Pr
es
en
t
H
yp
er
se
ns
iti
ve
to
al
ky
Ïat
ing
an
d
o
x
id
iz
in
g
ag
en
ts
A
PN
2
A
PE
I
A
PE
2
A
pn
2
A
PE
1
A
PE
2
Ex
o
III
Ex
o
III
Ex
o
III
2+
2+
2+
M
g
M
g
M
g
ED
TA
ED
TA
ED
TA
52
0a
a
31
7a
a
51
$a
a
59
.4
5
kD
a
35
.4
2
kD
a
57
.4
kD
a
3%
95
%
W
ea
k
30
-t
o
40
-fo
ld
10
0-
to
20
0-
St
ro
ng
m
o
re
ef
fic
ie
nt
fo
ld
le
ss
th
an
A
P
ef
fic
ie
nt
th
an
en
do
nu
cl
ea
se
P?
AP en
do
nu
çl
ea
se
30
-t
o
40
-fo
ld
10
0-
to
20
0-
R
ob
us
t
m
o
re
ef
fic
ie
nt
fo
1d
le
ss
th
an
A
P
ef
fic
ie
nt
th
an
en
do
nu
cl
ea
se
‘
A
P
en
do
nu
cl
ea
se
A
bs
en
t
Pr
es
en
t
A
bs
en
t
Se
ns
iti
ve
to
Er
nb
ry
on
ic
G
ro
w
th
ai
ky
la
tin
g
le
th
al
in
n
u
il
re
ta
rd
at
io
n
in
ag
en
ts
m
ic
e
n
u
l!
m
ic
e
1$
the endo IV family, the high-resolution structure of E. cou endo IV suggests that this
AP endonuclease and its homologues may use the classic agf3s TIM banel fold to
promote flipping of both the AP site and its orphan nucleotide out of the duplex with
a 900 bend in the DNA, but allowing only the damaged nucleotide in the enzyme
active site pocket [67]. The conformational changes induced in endo IV upon DNA
binding would allow the AP site to directly make contact with the three Zn2 ions,
which are essential for the catalytic activities of ail endo IV-related AP endonucleases
[67]. Thus, solving the crystal structures of representative AP endonucleases has
provided the structural basis for understanding the catalytic rnechanism of the exo III
and endo IV family members [60].
E. cou AP endonucleases
Exo III
The exo III enzyme, encoded by the xth gene, was initialiy identified as a
( phosphatase-exonuclease, but subsequently was discovered to be the major
constitutive AP endonuclease in E. cou extracts. Exo III is a 26$ amino acid enzyme
with a molecular mass of 31 kDa and accounts for approximatively 90% of the
cellular AP endonuclease activity [59,68,69]. Exo III is also endowed with a strong
3’-phosphodiesterase activity, an efficient 3’-5’ exonuclease activity, and an
endonuclease activity at urea residues in oxidized DNA [70]. E. cou mutants lacking
exo III (xthA) are sensitive to oxidizing agents such as H202 and are hypersensitive to
UVB light [7 1-74]. A recent study clearly suggests that exo III plays a crucial role in
the repair of UVB-induced toxic lesions, as pre-treatment with dipyridyl (an iron
chelator) completely restores wild-type resistance in the xthA strain [74]. Dipyridyl
prevents the Fenton reaction (Fe2 + F1202 —> Fe3 + Q14 + 0W) to occur via the
chelation of a fenous iron (Fe2), thus protecting ceils from ROS-induced DNA
lesions [74]. In fact, several studies have demonstrated that xthA strains accurnulate
large amounts of unrepaired ssb with blocked 3’ termini which are genotoxic
damages [73,75].
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EndoIV
The xth mutants possess a residual (10%) AP endonuclease activity that
displays no requirement for metal ions. A large-scale screening of clones
overexpressing a Mg2tindependent AP endonuclease activity lcd to the isolation of
the nfo gene which encodes the endo IV protein. The nfoA mutant is less sensitive to
oxidative and aikylating agents (e.g. FT202 and MMS, respectively) as compared to
the xthA strain, indicating that endo IV serves as an back-up enzyme in the repair of
AP sites [75]. However, recently, endo IV was demonstrated to play a determinant
role in the avoidance of UVB-induced mutagenic lesions [74]. Moreover, the protein
expression levels of endo IV can be induced more than 20-fold by paraquat, a
superoxide-producing agent. The up-regulation of endo IV may be important during
oxidative stress or when certain DNA lesions are refractory to repair by exo III [76].
S. cerevisïae AP endonucleases
C Apn]
In the budding yeast L cerevisiae, Apnl is the predominant AP endonuclease
representing more than 90% of the total AP endonuclease activity [77]. Apnl was
first described as a 3’-phosphodiesterase since the purified Apnl cleaved synthetic
DNA substrates containing 3’-phosphoglycolaldehyde esters [77]. Both the AP
endonuclease and 3’-phosphodiesterase activities of yeast Apnl showed no metal
requirement similarly to bacteria endo IV [77-79]. Screening a yeast 2gt1 1 expression
cDNA library in E. cou using a polyclonal antibody produced from the purified Apnl
lead to the successful identification of the AFNJ gene [$0]. Comparison of the
primary structure of Apn 1 with that of E. cou endo IV reveaÏed that the yeast protein
is indeed homologous to endo IV and bears an extra $2 amino acid residues at the C-
terminus [$0,81]. This additional C-teminal region of APN] contains a bipartite
nuclear localization signal (NLS) which when deleted causes cytoplasmic
accumulation of Apnl [$1]. Moreover, we have previously demonstrated that Pin, a
cell wall constituent, interacts with Apnl bipartite NLS, causing Apnl to translocate
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into the mitochondria [$2]. We observed in pir]A mutants a striking nuclear
accumulation (‘—3-fold) of Apnl, which coincided with drastically reduced levels in
the mitochondria [$2]. Apnl encompasses several enzymatic activities: (j) an AP
endonuclease activity, that hydrolyses the phosphodiester backbone 5’ to an AP site
[1], (ii) a 3’ -phosphodiesterase activity, that removes 3’ DNA-blocking groups such
as 3’ -phosphates, 3’ -phosphoglycolates, and 3’ -ct, 13-unsaturated aldehydes [11, (iii) a
3’-tyrosyl-DNA phosphodiesterase activity, that hydrolyzes the tyrosine residue of
topoisomerase I linked to a 3’ DNA end [$3], (iv) an endonuclease activity, that nicks
5’-side of oxidatively damaged DNA bases such as fapyA and FapyG [84], and (y) a
3’—>5’ exonuclease activity, that removes either a 3’-terminal nucleotide at a nick or a
misincorporated $-oxo-dGuo [85,86].
Apnl-deficient strains of S. cereviasiae display hypersensitivity to H202 and
MMS which produces ssb with blocked 3’-termini and abasic sites, respectively [40].
Interestingly, apn]A nuli mutants are not sensitive to bleomycin, suggesting the
presence of another enzyme more proficient at removing bleomycin-induced 3’-
C blocking groups. Loss of Apnl resuits in a 10- to 15- fold increase in the nuclear
spontaneous mutation rate [40]. The mutations correspond mainly to AT to CG
transversions [$7]. The high frequency of spontaneous mutations in the apnli nuil
mutants is primarlly due to unrepaired AP sites [8$]. Deletion of Apnl has no effect
on the rates of spontaneous mitochondrial mutations. However, when Apnl-deficient
cells are exposed to MMS, they dispïay approximately 6-fold increase in
mitochondrial spontaneous mutation rates, suggesting an important role of Apnl in
the repair of darnaged mitochondrial DNA [$2,89].
Apn2
A residual (5%) AP endonuclease activity was partially purified initiaÏly by
Sander and Ramotar [90] and termed Pde (3’-phosphodiesterase). Later, Johnson et
aï. independently characterized the Pde protein and renamed it Apn2 [$9]. Apn2
shares 36% and 33% sequence homology with E. cou exo III and human APE1,
respectively [89,91]. In addition to its AP endonuclease activity, Apn2 also contains
3’-phosphodiesterase and 3’—÷S’ exonuclease activities [92]. These two latter
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activities of Apn2 were estimated to be 30- to 40-fold higher than its AP
endonuclease activity [92]. Furthermore, a direct interaction of Apn2 with PCNA
strongly stimulates its 3’-phosphodiesterase and the 3’—>5’ exonuclease activities
[93].
Ceils deficient in Apn2 are less sensitivity to MM$ than the apn]A strains.
However, apn]Aapn2A double mutants are 1 5-fold more sensitive to MM$ and 2- to
3-fold more sensitive to H202 and bleomycin than apn]zl single mutants [91,94]. The
apn]Aapn2A mutant strains show both enhanced spontaneous and MM$-induced
mutation rates in comparison to the wild type [$9,91]. The expression of Apn2 in
apnMapn2A mutants restores some resistance to MMS and partially decreases the
rate of spontaneous mutations [91]. Together, these observations indicate that Apn2
provides important back-up DNA repair activities for Apnl.
Human AP endonucleases
AFE]
In humans, the exo III-related protein APE 1 (also called Ref- 1, HAP 1, and
APEX1) is considered the major AP endonuclease, representing approximately 95%
of the total cellular AP endonuclease activity [95-9$]. APE1 harbors its own bipartite
NLS, located within its N-terminal 20 amino acid residues, which allows for its
nuclear import but also localization to the mitochondria following cleavage by an
unknown specific mitochondria-associated peptidase [99,100]. APE1 is also endowed
with a 3’-phosphodiesterase as well as a 3’—+5’-exonuclease activity, which are much
weaker than its AP endonuclease activity [1]. Moreover, Gros et aï. demonstrated that
APE1 is also capable of incising directly 5’ of oxidative base lesions, sucli as 5,6-
dihydro-2-deoxyuridine, in a DNA glycosylase-independent manner [101].
The biological importance of APE1 is underlined by the embryonic lethality
in knock-out mice and the lack of stable APE 1 -deficient celI fines [102]. Recently,
Fung and Demple addressed the cellular role of APE1 by using RNAi tecbnology
[103]. They showed that APEY downregulation blocked cdl proliferation and
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stimulated apoptosis, which was correlated with accumulation of AP sites [103].
These effects were reversed by expression of S. cerevisiae Apnl, a protein that is
structurally unrelated to APE 1 but shares several enzymatic activities in the repair of
AP sites [1031 [104]. Their resuits clearly establish that APE1 plays a vital role in the
repair of endogenous DNA damage that, when lefi unrepaired triggers apoptotic celi
death.
APE2
To date, no endo IV homologs have been identified in human celis. In their
own search for nove! human AP endonuclease/3 ‘-phosphodiesterase enzymes, Hadi
and Wilson have however identified a second exo Ili-like protein termed APE2 [105].
The ubiquitously expressed APE2 enzyme is composed of 51$ amino acids with a
predicted molecular mass of 62 kDa and shares significant amino acid sequence
similarity to the core nuclease domain of APE1 and exo III (29% and 27% sequence
identity, respectively) [105]. Peptide sequence comparison revealed that APE2 lacks
the extended N-terminal domain present in APE 1 but possesses a longer C-terminal
region, which is absent in APE1 and exo III, thus indicating the existence of a second
exolli-like subfamily. This new exo lil-like subgroup comprises also of S. cerevisiae
Apn2 and S. pombe Apn2 [106].
An initial insight into the biological significance of APE2 was provided by
homozygous APE2-null mice which exhibited growth retardation and
dyshematopoiesis accompanied by G2/M arrest [107]. To shed more light on the role
of human APE2, Burkovic et al. expressed recombinant APE2 in yeast and showed
that recombinant enzyme exhibits a weak AP endonuclease activity, but shows strong
3’—5’ exonuclease and 3’-phosphodiesterase activities that act preferentially on
mistmatched 3’-nucleotides from DNA [10$]. Moreover, mutational analysis revealed
that Asp177 is an active site residue ofAPE2 [10$]. This study strongly suggests that
the intrinsic activities of APE2 are determinant in the removal of 3’-blocking termini,
as well as in the proofreading oferrors incorporated by DNA polymerases [10$].
23
APE] more than a DNA repair enzyme
APE1 is also known as Ref-1 (redox effector factor-1) due to its redox activity
that acts on redox-sensitive transcription factors [109]. APE 1 /Ref- 1 was first found to
copurify with the transcription factor AP-1 during column chromatography [110].
Subsequently, APE1/Ref-1 was demonstrated to reduce the conserved cysteine
residues in the DNA binding domains of c-Fos and c-Jun, the two subunits of AP-1,
thus promoting the binding to their DNA cognate sequences [97]. Since then,
APE1/Ref-1 has been shown to modulate the DNA binding activities, and thus the
transcriptional regulatory potential of proteins such as NF-KB (nuclear factor-KB),
Myb, HIf-YŒ (hypoxia inducible factor-1Œ) and p53 via a redox mechanism [111].
The redox function of APE1/Ref-1 is located in the N-terminal 127 amino
acids, whereas its nuclease activity resides in the C-terminal 157 amino acids [112].
The nuclease region of APE 1 /REf- 1 shares a high degree of sequence homology with
other functionally related repair proteins such as bacteria exo III and fruit fly Rrp 1,
but the redox domain is present only in mammals [112]. The redox activity of
APE1/Ref-1 may have evolved to sustain embryonic development, since deletion of
an exo Ili-like protein does flot cause lethality in lower organisms [112]. However, at
the cellular level, APE1/Ref-1 nuclease function is more important for the repair of
spontaneous DNA damage that, when accumulated, can induce celi death
[102,112,113]
Regulation of APE1 activities
Considering the key roles of APEY in DNA repair and gene regulation, the
ccli has developed several strategies to regulate the APEY enzyme at both the
transcriptional and posttranslational levels [111]. In terms of transcriptional
regulation, it has been shown that ROS, such as H202, induce APEY mRNA, which
correlates with an increase in APE1 protein levels and activity [114]. APE1 cellular
functions are further modulated through two non-mutally exclusive posttranslational
mechanisms, namely subcellular localizations and posttranslational modification
[115]. Upon exposure to ROS, APE1 accumulates in the nucleus as a resuit ofboth an
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increased in nuclear transiocation and a decreased in nuclear export via the binding of
its bipartite NLS with nuclear importins cd and Œ2 and the inhibition of its nuclear
export signal, respectively [99]. Several posttranslational modifications, such as
acetylation, phosphorylation and oxidation/reduction have been reported to influence
APEI functions [111,115]. Acetylation of APE1 by p300 was shown to affect the
transcriptional regulatory function ofAPE1 [1 15]. However, the reports on the impact
of phosphorylation by PKC (protein kinase C), CKI and CKII (casein kinase I and II,
repectively) on APE1 activities remain inconsistent [1 15]. Some studies suggest that
phosphorylation of APE1 might abolish its AP endonuclease activity [1151.
The redox status of APE1 is another important regulatory factor determining
its cellular activities [111,115]. Hirota et al. demonstrated that thioredoxin (TRX), an
endogenous dithiol-reducing molecule, acts as a hydrogen donor for APE 1. Reduced
APEI, in tum. potentiates the DNA-binding and transactivation abilites of AP-l
[116]. In a similar maîmer, TRX and APE1 cooperate in the control of basal p53
stability and activity [117]. While reduction of APE 1, on the one hand, appears to be
a positive reguÏatory mechanism for its transcriptional functions, oxidation, on the
other, lias a negative impact on APE1 AP endonuclease activity [118]. Treatment of
APE1 with oxidizing agents, such as H202 and diamide, causes a significant decrease
in AP endonuclease activity, which was neutralized by the addition of certain
amounts of DTT, suggesting a direct effect of oxidation [11$]. Furthermore, site
directed mutagenesis studies revealed that Cys3lO residue of APE1 is likely to be
oxidized, whereas Cys63 and Cys95 are most susceptible to a reduction reaction
[115] [112].
Protein-protein interactions involving APE1
APE1 has been demonstrated to be an important modulator of the multi-step
BER pathway. APE1 accomplishes this regulatory role mainly through physical
and/or functional protein-protein interactions with both up- and down-stream BER
enzymes (Table I-IV) [115]. BER is initiated by DNA glycosylases which recognize
and excise a damaged base leaving behind an AP site. The activity of several
25
Q glycosylases, such as OGGI [119], UNG [120], TDG [121] and NIH1 [122], isstimulated by an association with APE 1. However, only TDG and MYH interact
physically and form stable complexes with APE1 [121,123]. Since most of the
glycosylases display a high affinity for base lesions and AP sites, APE1 is thought to
stimulate the dispiacement of the glycosylases from their DNA products via protein
interactions, thus facilitating glycosylase turnover. APE1 was shown to interact also
with downstream BER proteins, sucli as fEN1 [124], Pol 3 [1251, PCNA t124],
XRCCI [126] and LIG1 [127]. In these interactions, the AP endonuclease modulates
its patner’s activity, with the exception of XRCC1, which alters the ftmctions of
APE1 (see Table I-IV).
Adding to its complex network of protein interactions with BER proteins,
APE1 also interacts with proteins participating in other cellular processes, such as
transcription and replication. APE1 was demonstrated to interact with WRN (Werner
syndrome protein), PARP (Poly(ADP-ribose) polymerase 1), HSP7O (heat-shock
protein 70), and the tumor-suppressor protein p53 [128-132]. The effects of these
various interactions are summarized in Table I-IV.
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G Table I-IV. Effects of the various proteins interactions involving APE1 on theBER pathway.
Interacting patner Conseguence of the interaction Reference
BER proteins
UDG StimuÏates dispiacement ofUDG from AP sites [120]
TDG Stimulates the turnover o [121]
f TDG at A? sites
MYH Facilitates the release ofMYH from its DNA [123]
products
FEN1 Enhances both the exo- and endonuclease [124,127]
activities ofFEN1
Stimulates LP-BER
Pol fi Stimulates the 5’-dRP lyase activity of Pol fi [125]
PCNA Coordinates LP-BER [124]
XRCC1 Increases APE1 A? endonuclease and 3’- [126]
phosphodiesterase activity
Promotes SP-BER
LIG1 Stimulates DNA ligase 1 activity [127]
Other prote ins
WRN Inhibits WRN helicase activity on BER [128]
intermediates
PARP Blocks APE1 stimulation ofstrand-displacement [129]
DNA synthesis by Pol f3
Inhibits the exonuclease activity ofAPE1
HSP7O Stimulates APE I AP endonuclease activity [1301
p53 Stimulates p53 DNA binding by promoting its [132]
tetramerization
Induces p53 transactivation and pro-apoptotic
activities
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HYPOTHESIS AND OBJECTIVES
AP endonuclease enzymes are crucial players in the BER pathway. They are
grouped into two distinct familles, the exo III famiÏy and endo IV family. Celis
lacking AP endonuclease activity are hypersensitive to oxidizing and alkylating
agents, such as H202 and MMS, which induce ssb with blocked 3’-termini and AP
sites, respectively. We were particularly interested in understanding the molecular
mechanisms by which eukaryotic AP endonucleases maintain genomic integrity in the
nucleus as well as in the mitochondria. We set out to study the structure/function
andlor protein interactions of AP endonucleases, which could provide us with
valuable insights into their mechanisms of binding and cleavage of oxidative DNA
lesions as well as their regulation inside the celi. In our first study (Chapter 2) which
aimed at identifying the critical arnino acid residues of S. cerevisiae Apnl for its
biological function, we showed by mutational analysis that G1u15$ and Asp192 are
crucial for the DNA repair functions of Apnl. In our second study (Chapter 3), we set
out to evaluate the role of yeast Oggl DNA glycosylase in the maintenance of a
mitochondrial poly(GT) tract reporter system. Interestingly, we discovered that
overproduction of Apnl triggers instability of the poly(GT) tract, but which was
counteracted by the simultaneous overexpression of Oggi. In our third study (Chapter
4), we initially aimed at purifying an endo IV homolog in human celis. However, the
goal of this project changed when we unexpectedly re-isolated GAPDH, a well
established glycolytic enzyme, during our purification of a Mg2tindependent AP
endonuclease. We demonstrated that GAPDH physically interacts with APE1 to
reduce the oxidized forms of APE1, which resulted in the reactivation of the AP
endonuclease activity. In addition, we demonstrated the importance of Cys 152 and
Cys 156 residues of GAPDH in the reactivation of APE 1 by site-directed mutagenesis.
The biological importance of GAPDH in the cellular protection against genotoxic
agents, which induce APE1-repairable lesions, was further supported by clonogenic
assays using human colon carcinoma celis overexpressing GAPDH or knockdowned
for GAPDH.
oCHAPTER 2
Cliaracterization of two independent amino acid
substitntions that disrupt the DNA repair
functions of the yeast Apnl
Published in Biochemistrv 2003, Vol. 42, No. 21, pp. 6436-6445.
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(r ABSTRACT
The members of the Endo IV family of DNA repair enzymes, including
$accharomyces cerevisiae Apnl and Escherichia cou endonuclease IV, possess the
capacity to cleave abasic sites and to remove 3’-blocking groups at single-strand
breaks via apurinic/apyrimidinic (AP) endonuclease and 3 ‘-diesterase activities,
respectively. In addition, Endo IV family members are able to recognize and incise
oxidative base damages on the 5’-side of such lesions. We previously identified eight
amino acid substitutions that prevent E. cou endonuclease IV from repairing damaged
DNA in vivo. Iwo of these substitutions were glycine replacements of G1u145 and
Asp179. Both G1u145 and Asp179 are among nine amino acid residues within the
active site pocket of endonuclease IV that coordinate the position of a trinuclear Zn
cluster required for efficient phosphodiester bond cleavage. We now report the first
structure-function analysis of the eukaryotic counterpart of endonuclease IV, yeast
Apnl. We show that glycine substitutions at the corresponding conserved amino acid
residues of yeast Apnl, i.e., G1u158 and Asp192, abolish the biological function of
this enzyme. However, these Apnl variants do flot exhibit the same characteristics as
the corresponding E. cou mutants. Indeed, the ApnÏ GluI5SGly mutant, but not the
E. cou endonuclease IV Glul45Gly mutant, is able to bind DNA. Moreover, Apnl
Aspl92Gly completely lacks enzymatic activity, while the activity of the E. cou
counterpart Aspl79Gly is reduced by —4O-fo1d. The data suggest that although yeast
Apnl and E. cou endonuclease IV exhibit a high degree of structural and functional
simiÏarity, differences exist within the active site pockets ofthese two enzymes.
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INTRODUCTION
Apurinic/apyrimidinic (AP) sites, produced in cellular DNA both
spontaneously and by many chemical mutagens (e.g., oxidative and aikylating
agents), are highly genotoxic and must be repaired by AP endonucleases to prevent
genetic mutations [1,133]. The yeast Saceharomyces cerevisiae possesses a 40.5 kDa
DNA repair enzyme, Apnl, which is localized to the nucleus as weÏl as to the
mitochondria [40,81,82]. Apnl is a key component of the base excision repair
pathway, and functions to hydrolyze AP sites by cleaving the DNA backbone 5’ to the
AP site to produce a 3-hydroxyl group and a 5’-deoxyribose phosphate [40,78,133].
The 5-deoxyribose phosphate is then removed by a 5’-deoxyribose
phosphodiesterase, such as yeast Rad27, to create a gap which is then fihled in and
sealed by the sequential action of DNA polymerases and DNA ligase [134,135].
ApnÏ also possesses a 3’-diesterase activity, which removes a multitude of 3’-
blocking groups (e.g., 3’-phosphoglycolate and 3-phosphate) at DNA single-strand
breaks induced by oxidative agents, including the antitumor drug bleomycin and
hydrogen peroxide (H202) [77,78]. More recently, we have shown that Apnl
recognizes and cleaves oxidized bases immediately 5’ to the lesion to create a 3’-
hydroxyl group [84]. This enzyme is atso able to act on nicked DNA to remove the 3’-
nucleotide, thereby generating a single-nucleotide gap [84]. Thus, Apnl can be
viewed as having multiple enzymatic activities.
Mutants lacking Apnl (apn]A) are hypersensitive to the aikylating agent
methyl methane sulfonate (MM$) due to defective repair of MMS-induced AP sites
[136], and also display a 10- to 15-fold increase in the rate of spontaneous AP site
induced single base-pair mutations [87,88,137]. apn]A mutants are not sensitive to
agents that generate DNA strand breaks with blocked 3’-terrnini due to the presence
of another compensating AP endonuclease/3’-diesterase activity, i.e., Apn2 (also
called Pdel and Ethi) [89,91]. When both APN] and AFN2 genes are deleted, the
resulting apn]Aapn2A double mutant is exquisitely sensitive to MMS, and displays
hypersensitivity to agents such as H202 that creates strand breaks terminated with 3’-
blocking groups [89].
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Apnl belongs to the Endo IV family of DNA repair enzymes, which is
exemplified by Escherichia cou endonuclease IV (endo IV) [133]. Recent studies
have shown that Apnl/endo IV homologues also exist in the fission yeast
$chizosaccharomyces pombe, as well as in the nematode Caenorhabditis elegans,
underscoring the importance of Endo IV family members in the repair of damaged
DNA [133]. These members share five highly conserved regions (RT-RV) that are
distributed along the entire length of the proteins [1331. For example, the RuT region
contains a stretch of amino acid residues (KSRxGVCIDTCHxFAxGYD) that are
identical in all members [133]. Consistent with this substantial degree of amino acid
sequence homology, cross-species complementation revealed that Endo IV family
members are also highly ftmctionally conserved. For example, yeast Apnl can
substitute for E. cou endo IV and vice versa [138]. However, despite the high degree
of evolutionary conservation among Endo IV family members, no corresponding
homologue has yet been found in human cells [133].
We have been interested in elucidating the mechanism by which E. cou endo
C IV recognizes and cleaves phosphodiester bonds at sites of DNA damage. Using
chemical mutagenesis, we previously identified eight essential amino acid
substitutions that alter endo IV function with respect to both AP site cleavage and
removal of blocked 3’-termini [139]. Indeed, mutants bearing these substitutions
showed parallel reductions of AP endonuclease/Y-diesterase activities, ranging from
10- to 15 0-fold [139]. One of the mutants, bearing the substitution E 145G located in
the conserved region RIT, actually prevented endo IV from binding to DNA [139].
Other substitutions destabilized the protein and were deemed essential for the proper
maintenance ofthe tertiary structure [139]. Concurrent with our reported findings, the
high resolution atomic structure of endo IV was published and assigned the side chain
of fine amino acid residues as coordinating a trinuclear Zn cluster within the active
site pocket of the enzyme. Among our own panel of endo IV mutants are variants in
which two of these nine amino acid residues (i.e., either Glu145 or Asp 179) have
been replaced with glycine [139]. We therefore set out to investigate if the
corresponding conserved amino acid residues ofApnl (i.e., G1u158 and Asp192) are
( also essential for biological function. Our data clearly reveal that glycine substitution
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at either G1u158 or Asp 192 of Apnl prevents the mutant protein from repairing
damaged DNA in vivo, although these mutants differ substantially from their endo W
mutant counterparts. We suggest that Apnl and endo IV use slightly different
mechanisms to catalyze the processing of damaged DNA.
C
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MATERIALS AND METHODSe
Strains, media, genetic analysïs, and transformation
The bacterial strains used in this study were the parent AB1157 and the
mutant BW528 [A(xth-pnc), nfo].:kan)] (kindly provided by Dr. B. Weiss, Emory
University, Atianta, GA). The bacteria were transformed with the indicated vector or
plasmid (see below) by the CaCI2 method. The E. cou strain used for plasmid
maintenance was DH5Œ. The S. cerevisiae strains used in this work were YW465
(M4Taade2AO his3A-200 leu2A-] met]5A0 trplA-63 ura3AO), YW605 (isogenic to
YW465, except apn]A:.H153), and YW781 (isogenic to YW465, except
apnlA: .11153 apn2A. :KanMX4) and were generously provided by T. Wilson (Ann
Arbor, MI). Yeast celis were grown in either complete yeast peptone dextrose (YPD)
or minimal synthetic (SD) medium, to which standard nutritional supplements had
been added at 20 ig/mL. Transformation were carried out as described previously
[140].
Construction of the plasmids GFP-APN1 and GST-APN1
The APN] gene (bp —13 to +1383) was amplified by polymerase chain
reaction (PCR) from the plasmid YepApn] using the primers APNY-f1-EcoRl (5’-
‘3CGGAACCATCGAATTCCCTTCGACACCTAGCTTTG2’-Y) and DR-2B (5’
‘383CCATAAGAGGATGGTCGACCGCCTTCCTTAG’ 35331) bearing the restriction
sites (underlined) for EcoRI and Sa/I, respectively. The amplified 1.4 kb DNA
fragment was digested with EcoPJ and SalI and subcloned downstream of the green
fluorescent protein (Gfp) gene, which is under the control of the GAL] promoter in
the yeast expression vector pYES2.0, to produce the plasmid pGFP-AFN]. In a
similar fashion, the fragment was cloned downstream of the glutathione 5-transferase
(Gst) gene and placed under the control of the lac promoter in the E. cou expression
vector pGEX-4T-1 (Amersham Pharmacia Biotech) to produce the plasmid pGST
APN].
o
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plates were inverted, uncovered, and dried in a 37°C incubator for 1 h. Then bacterial
or yeast cells were replicated as a thin une along the drug gradient, and photographed
afier 24 h of growth at 3 7°C. Growth along the gradient (82 mm) is considered to be
100%.
Immunodetection
The proteins were separated on 10% SDS-PAGE gel and transfened onto a
nitrocellulose membrane (2 cm x 10 cm) (Amersham Life Science) which was then
blocked with TSE buffer [10 mM Tris-HC1 (pH 7.45), 150 mM NaCI, 0.1% Tween,
and 1 mM EDTA] containing 5% powdered milk for 1 h. The membrane was probed
for 16 h at 4°C with 10 mL of TSE containing anti-Gfp monoclonal antibodies
(Clonetech) at a dilution of 1:5000. following the probing, the membrane was
washed three times for 15 min each time with TSE before addition of 10 mL of the
anfi-mouse IgG conjugated to horseradish peroxidase at a dilution of 1:2500
(BIO/CAN Scientific, Inc.) for 1 h at room temperature. finally, the membrane was
washed again three times for 15 min each time with TSE, and immunoreactive
polypeptides were detected by chemiluminescence (Dupont-NEN).
Purification of Apnl, Gst-Apnl and the mutant forms
BW52$ ceils bearing the plasmids pG$T-APN], pGST-AFN](E]58G), and
pG$T-AFNJ (D] 92G) were grown ovemight at 30°C in $ mL of LB containing 100
ig/mL ampiciflin, and then subcultured into 250 mL LB medium containing 100
tg/mL ampicillin to an OD of 0.6 at 600 nm. IPTG (Sigma) was then added to a
final concentration of 1 mM, and the culture was grown for an additional 140 min.
Celi pellets were resuspended in 2.5 mL of buffer A which consisted of 50 mM Tris
HC1 (pH 7.5), 100 mM NaC1, 0.5 mM EDTA, 0.5 mM DIT, and the protease
inhibitor cocktail (Complete Mini, EDTA-free, Roche Diagnostics GmbH). Cell
extracts were prepared as previously described [141] with the slight modification of
using three freeze-thaw cycles (freezing in ethanol/dry ice freezing bath and thawing
37
at 37°C). Extracts were then sonicated 2 x 5 s (at 50% power), centriftiged at 12 000
L
rpm at 4°C, and the supematants were loaded onto a 0.25 mL glutathione-Sepharose
43 mini column (Amersham Pharmacia Biotech) pre-equilibrated with buffer A. The
column was washed three times with buffer A and eluted with 500 jiL of 50 mM Tris
HC1 (pH 8.0) containing 10 mM reduced glutathione. The eluted proteins were
dialysed in a SpectralPor 1 dialysis tube (MWCO 6K-8K, Spectrum) against 500 mL
of buffer A for 3 h with three intervening changes. The dialyzed proteins were loaded
onto a 50 pL Macro-Prep 50S (Bio-Rad) mini column pre-equilibrated in buffer A,
and the fiow-through fractions containing the Gst-ApnÏ or the Gst-Apnl mutants
were collected and concentrated in a 4.0 mL capacity 10K cut off Ultrafree Biomax
concentrator (Millipore Corp.) to 150 tL. The concentrations of the proteins were
determined according to the method ofBradford [142].
The open reading frame DNA encoding Apnl was cloned into pETila
(Novagen, Madison, WI) and the protein overexpressed in E. cou BL21 Star ceils
(Invitrogen SARL, Gergy Pontoise, France). Purification of the protein was achieved
using three chromatographic steps: DEAE-sepharose (Waters), sulfopropyl Sepharose
cation exchange (Amersham Biosciences, Littie Chalfont, UK) and AcA54 gel
filtration (IBF, Villeneuve-la-Garenne, france).
AP endonuclease and 3’-diesterase assays
For the AP endonuclease assay, a 42-mer U21G oligo (5’-
GCTGCATGCCTGCAGGTCGAUTCTAGAGGATCCCGGGTACCT-3’) containing
a single uracil at position 21 was labelled at the 5-end by T4 polynucleotide kinase
(PNK) (Gibco) using [y-32P]ATP (Pharmacia), and anneaÏed to the complementary
42-mer oligo (3’-CGACGTACGGACGTCCAGCTGAGATCTCCTAGGGCC-
CATGGA-5’) to generate the UG mismatch [143]. To create the AP site substrate,
this labelled double-stranded oligonucleotide was treated with uracil DNA
glycosylase (UDG) (New England Biolabs) for 30 min at 37°C. The AP
endonuclease assay and product resolution by urea-PAGE were performed as
previously described [139]. b generate the 3’-blocked termini, the labelÏed double-
3$
stranded oligonucleotide was treated with endonuclease III (kindly provided by Dr.
Melamede, University of Vermont, Burlington, VT) at 37°C for 1 h to convert ail the
AP sites into 3’-blocked ends. The 3-diesterase assay and analysis of the reaction
product by urea-PAGE were performed as previously described [139].
DNA glycosylase-independent incision of oxidatively damaged DNA
Oligodeoxyribonucleotides were purchased from Eurogentec (Seraing,
Belgium), including modified oligonucleotides containing either 5,6-dihydrouracil
(DHU), 5,6-dihydrothymine (DHT), or tetrahydrofuran (THF) residues: 5’-
TGACTGCATAXGCATGTAGACGATGTGCAT-3’ (30-mer), where X is the
position of the modified base, DHU or DHT. The complementary oligonucleotides
contained either dG or dA opposite the rnodified base. The resulting duplex
oligonucleotides were termed dHU/G and dHT/A. respectively. This sequence
context was previously used to study the repair of a thymine fragmentation product
[144]. Oligonucleotides were 5’-end labeïed by T4 polynucleotide kinase (New
England Biolabs, Beverly, MA) in the presence of [-32P]ATP (6000 Ci/mmol, ICN
Pharmaceuticals, Inc., Costa Mesa, CA) or 3’-end labeled by terminal transferase
(New England Biolabs) in the presence of [Œ-32P]dCTP (3000 Ci/mmol. Amersharn
Biosciences, Piscataway, NJ) as recommended by the manufacturers. The
oligonucleotides were then airnealed to the appropriate complements in buffer
containing 0.5x SSC [75 mM NaC1 and 7.5 mM citric acid trisodium salt (pH 7.0)] at
65°C for 5 min as previously described [145]. For determination of nucleotide
incision activity, 0.4 pmoÏ (or 0.2 prnoi for THf/G oligonucleotide) of5’-[32P]- or 3’-
[32P]-dCMP-labeled oligonucleotide duplex was incubated with 10 ng (or 5 ng for
THf/G oligonucleotide) of the given repair protein(s) for 30 min (or 10 min for
THf/G oligonucleotide) at 37°C in reaction buffer (20 tL) containing 50 mM HEPES
(pH 7.5), 50 mM KC1, 0.1 mM EDTA, 5 mM f3-mercaptoethanol, 0.1 mg/mL B$A.
When necessary, a light piperidine treatment was performed by adding 10%
piperidine for 15 min at 3 7°C. Reaction products were analyzed by electrophoresis on
denaturing 20% polyacrylamide gels (20:1, 7 M urea, 0.5x TBE), and visualized with
a Storm $40 by Phosphorlmager (Molecular Dynamics Inc.).
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4 Electrophoretic Mobility Shift AssayA 5’-32P-end-labeled 42-mer double-stranded oligonucleotide was used as a
probe for EM$A. Assays were performed as described previously [139]. In brief,
approximately 0.1 ng of the labeled probe (corresponding to 1.5 x cpm) was
incubated with 15 ng of wild-type and mutant Apnl proteins in buffer B [10 mM
Hepes-NaOH (pH 7.9), 20 mM KC1, 10% glycerol, 0.1 mM EDTA, 0.5 mM DTT, 1
mM PMSF] for 20 min at room temperature. The formation of protein-DNA
complexes was resolved by electrophoresis in a 140 cm x 175 cm x 0.75 cm, 6%
native polyacrylamide gel (19:1 acrylarnide:bisacrylamide ratio) in high-ionic
strength Tris-glycine buffer [50 mM Tris-HC1 (pH 8.8), 380 mM glycine, 2 mM
EDTA] at 100 V for 4 h at 4°C, dried, ami revealed by autoradiography [146]. The
sequences of the two different probes, 42-mer UG and 42-mer CG double-stranded
oligonucleotides, were 5’-GCTGCATGCCTGCAGGTCGAUTCTAGAGGATCCC-
GGGTACCT-Y and the complementary strand 3’-CGACGTACGGACGTCCAGC-
TGAGATCTCCTAGGGCCCATGGA-5 and 5-GGTCTAAACGTTTATGCCTTT-
GCTCTGGACCATACAATTATC-3’ and the complementary strand 3’-
CCAGATTTGCAAATACGGAAACGAGACCTGGTATGTTAATAG-5’,
respectively.
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RESULTS
The construct GFP-APN expresses a functionally active fusion protein
The full length ARNJ gene was inserted in frame into the pYES-GfP vector to
produce the plasrnid pGFP-APN1, which expresses the Gfp-ApnI fusion protein
under the galactose inducible GAL] promoter (see below and Materials and Methods)
[82]. To examine if the plasmid expressed a functionally active Gfp-Apnl fusion
protein, we tested for drug complementation in strain YW781 (apnlAapn2A) [85].
This strain lacks both Apnl and Apn2, and therefore is hypersensitive to various
DNA-damaging agents, including MMS and F1202, which that produce AP sites and
strand breaks with blocked 3-termini, respectively [$5,89]. Introduction of pGfP
APNÏ into strain YW781 conferred full parental resistance to MM$ (Figure 2-1, lane
6) and 11202 (data not shown), under noninducing conditions, as determined by
gradient plate assays. In this assay, the drug-sensitive strains grow only a short
distance into the gradient, whereas the resistant strains grow along the entire length of
the gradient [138]. As expected, the pYES-GFP vector provided no drug resistance to
strain YW781 (Figure 2-1, lane 5). The data suggest that plasmid pGfP-APN1
produces a biologically active fusion protein in yeast celis. It is noteworthy that the
GAL] promoter is leaky and produces enough Gfp-Apnl to restore drug resistance to
strain YW781. Overproduction of Gfp-Apnl by galactose induction conferred no
additional drug resistance to strain YW7$l (data flot shown). $imilar findings were
previously observed in yeast with untagged Apnl [40,81].
The Gfp-Apnl(E158G) and Gfp-Apnl(D192G) mutant plasmids confer no drug
resistance to the AP endonuclease-deficient strain YW781
We deterniined if glycine substitution of amino acid residues E158 and D192
interferes with the biological function of Apnl. The two substitutions, E158G and
D 192G, were created by altering the DNA sequence in plasmid pGFP-APN 1 by site
directed mutagenesis to produce the plasmids pGFP-APN1(E15$G) and pGFP
APN1(D192G), respectively. Introduction of either mutant plasmid into strain
ç
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O Figure 2-1. Drug resistance determination in S. cerevisiae strains YW465(parent) and YW781 (apnlAapit2A) harboring plasmids carrying either the
native or mutant alleles of the APN1 gene fuseil to GFP.
The resuits were obtained from gradient plate assays where the bottom layer
contained 0.015 mmol of methyl methane sulfonate (MMS). Growth along the
gradient is considered to be 100%. The picture was taken afier incubation for 1 day at
30°C.
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YW781 failed to confer resistance to MMS or F1202, as compared to the pGFP
APNY plasmid (Figure 2-l, lanes 7 and 8 vs lane 6, and data flot shown). Similar
resuits were obtained if the drug gradient plate assays were done under conditions of
galactose induction (data not shown). The data suggest that the plasmids pGFP
APN1(EI52G) and pGFP-APN1(D192G) arc likely expressing inactive mutant
proteins.
The Apnl mutant plasmids express normal levels of the mutant proteins and are
localized to the nucleus
To exciude the possibility that lack of complementation by these mutant
plasmids might merely reflect a reduction in the level of protein expression, we
examined levels of native and mutant proteins in total ccli extracts (Figure 2-2).
Extracts derived from either the parent, or strain YW78 I harboring the plasmid
pGFP-APN 1, expressed the expected 66 kDa full-length fusion protein foïlowing
galactose induction (0.5% for 4 h) (Figure 2-2, lanes 1 and 6, respectively). In the
absence of galactose induction, the Gfp-Apnl fusion protein could not be detected
with anti-Gfp antibodies (lanes 4 and 5), although under these conditions enough
Gfp-Apnl is expressed to fully restore drug resistance to strain YW7$l (Figure 2-l).
Total extracts prepared from either the parent or strain YW78 I harboring either of the
two mutant plasmids also exhibited normal expression levels of the 66 kDa fusion
protein (Figure 2-2, lanes 2, 3, 7, and 8, respectively). There was no significant
degradation of either mutant fusion protein, suggesting that these do not exhibit any
major structural deformation to trigger proteolysis, and thus are as stable as the native
fusion protein. Another possibility that could explain the inability of the Apnl
mutants to complement the drug hypersensitive phenotypes of strain YW7$ 1 might
involve prevention of protein transiocation into the nucleus. We therefore examined
the cellular location of the native and the mutant proteins by fluorescent microscopy
(sec Materials and Methods). The native Gfp-Apnl and the Apnl mutants
were mainly localized to the nucleus in both strains following induction with
C
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Figure 2-2. Comparison of the expression levels of native Apnl and its mutant
forms fused to Gfp.
Total protein extracts were derived from the indicated plasmid-bearing yeast strains
YW465 and YW7$1 following induction for 4 h with (+, lanes 1-3 and 6-8) or
without (-, lanes 4 and 5) 0.5 ¾ galactose. Each lane contains 100 j.ig of total extract.
and the Western blot was probed with a monoclonal anti-Gfp antibody. The arrow
indicates the position of the native and mutant forms of Gfp-Apnl (66 kDa).
Molecular mass standards are shown at the lefi.
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galactose (Figure 2-3). We conclude that the two plasmids pGFP-APNY(EY58G) and
pGfP-APN1(D192G) are indeed expressing the mutant protein, and that the mutant
proteins do flot harbor a defect in entering the nucleus, supporting the notion that
these mutant proteins lack the ability to repair damaged DNA.
Expression anti complementation analyses of Gst-Apnl and the Gst-Apnl
mutant forms in the DNA repair deficient E. cou strain BW528
b determine if the Apnl(E15$G) and Apnl(D192G) mutants have a defect in
repairing damaged DNA, we designed an E. cou expression system to facilitate the
purification of these proteins. The genes encoding the native APN] and the two
mutant alleles, APN](E]58G) and APN](D]92G) were inserted in frame with the
glutathione-S-transferase gene Gst in the vector pGEX-4T-1 to create a set of three
plasmids [pGST-APN 1, pGST-APN 1 (E 1580), and pGST-APN 1 (D 192G)], which
were designed to produce Gst-Apnl, Gst-Apnl(E158G), and Gst-Apnl(D192G)
fusion proteins, respectively, under the control of the IPTG-inducible lac promoter.
The plasmids were introduced into the E. cou strain BW528, which in a manner
analogous to that of its yeast counterpart strain YW781 is deficient in AP
endonuclease activity, i.e., is lacking both endonuclease IV and exonuclease III
genes. This E. cou strain is also hypersensitive to various DNA-damaging agents
because of an inability to repair damaged chromosomal DNA [136]. Total extracts
derived from the exponentially growing E. cou strain BW528 canying either plasmid
pG$T-APN1, pGST-APNÏ(E158G), or pG$T-APN1(D192G), and induced by IPTG,
expressed the expected 66 kDa fusion protein as observed by Coomassie staining
(Figure 2-4A). The expression levels were similar for all three proteins and no major
degradation was observed (Figure 2-4A).
We previously showed that expression of Apnl complemented the drug
hypersensitivities of strain BW528 [136]. We therefore tested if the fusion form of
Apnl, Gst-Apnl, was also capable of complementing the drug
hypersensitivites of strain BW528 [136]. Introduction of the plasmid pGST-APN1
C
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Figure 2-3. Nuc]ear Iocalization of Gfp-Apnl and its mutant forms. Fluorescent
analysis were performed with strains YW465 (parent) and YW781 (apn]Aapn2A)
(YW77$) bearing either the pGfP-APN1, or pGFP-APN1(E15$G), or pGFP
APNÏ(D192G) plasmid. Ceils were grown in selective medium with 2% raffinose and
induced with 0.5% galactose for 4 h before being photographed at a magnification of
100 times with a Cool Snap camera attached to the Leitz irnmunofluorescent
microscope.
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Figure 2-4. Expression and purification of native and mutant forms, E158G and
11192G, ofApnl usingE. cou.
(A) Coornassie blue-stained SDS-PAGE gel of total extracts derived ftom strain
BW528, and canying either the pGST vector or the pGST-APN1 plasrnid or the
mutant forms: lane 1, molecular mass standards; and lanes 2-5, pG$T, pGST
APN 1 (pAPN 1), pGST-APN 1 (pE 158G), and pGST-APN I (pD 192G), respectively.
Each lane (lanes 2-5) contained 60 tg of total protein extract. The plus and minus
signs indicate whether the lane did or did flot experience 1 mM IPTG induction. (B)
Glutathione-3-transferase affinity column purification of Gst-Apnl and its mutant
forms. Total extracts derived from strain BW528 carrying either the pGSI, pGST
APN 1 (pAPN 1), pGST-APN 1 (E 158G), or pGST-APN I (D 192G) plasmid were
purified on a Gst affinity column and analyzed on an SDS-PAGE gel stained with
Coomassie blue. Each lane (lanes 2-5) contained 200 ng of the affinity-purified
proteins. (C) Gst affinity-purified Apnl and the variants were subjected to ion
exchange chromatography on monoS and analyzed on Coornassie-stained gel. Each
lane (lanes 1-3) contained 200 ng of purified protein. For each panel, the anow
indicates the position of native and mutant forms of the fusion protein, Gst-Apnl.
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into strain BW52$, but flot the empty pGST vector (pGEX-41-1), restored parental
resistance to both MM$ and H202 (Figure 2-5A,B, lane 3 vs lane 5), suggesting that
the Gst-Apnl fusion protein is functionally active in bacteria, as is the Gfp-Apnl
fusion protein in yeast. It should 5e noted that the lac promoter appears to be leaky
since the drug complementation assay was performed in the absence of IPTG (Figure
2-5). However, in the presence of IPTG, Gst-Apnl confened no additional drug
resistance to strain BW52$ (data not shown). This is not surprising, as we have
documented similar findings with the overexpression ofApnl in strain BW52$ [136].
Introduction of the mutant plasmids, either pGST-APN1(E15$G) or pGST
APN1(D192G), into BW52$ conferred no resistance to MMS or H202 (Figure 2-SA
and B, lanes 1 and 2), cÏearly indicating that the mutant proteins expressed by these
plasmids are unable to act on the damaged DNA.
Apul mutants Iack DNA repair actïvities
We next examined the ability of the purified Gst-Apnl and the mutant forms
to process DNA lesions in vitro. Briefly, the Gst fusion proteins were affinity-purified
on a glutathione column followed by ion-exchange chromatography on monoS
(panels B and C of Figure 2-4, respectively). This second purification step was
necessary to remove trace contamination of AP lyase activity, which bound to the Gst
affinity column independent of Apnl. The purified Gst fusion proteins were assessed
for ah tbree enzymatic activities, i.e., AP endonuclease, 3’-diesterase, and the activity
that incises oxidized base lesions. To monitor AP endonuclease activity, we used a
labeled 42-mer double stranded oÏigonucleotide bearing a single AP site at position
21. Cleavage of the AP site substrate by AP endonucleases produces a labeled 20-mer
product which can be readily detected on 10% polyacrylamide gels [147]. As shown
in Figure 2-6A, the native Gst-Apnl, as wehl as purified endo IV, actively cleaved the
substrate to produce the 20-mer product (lanes 1, 2, and 7). Interestingly, following
the formation of the 20-mer product, purified Gst-Apnl was able to remove
additional nucleotides in a 3’ to S’-direction to create a smaller product (lane 1 or 2),
but flot the mutants even at higher protein concentration (>50 ng, data not shown).
Q
52
Q figure 2-5. Drug complementation analysis of strain BW52$ carrying plasmidsexpressing the native and mutant forms of Apnl fused to Gst.
AB Ï 1 57(endoIVexoIII) is the parent of BW528(endolVexollfl. The
complementation assays were performed on drug gradient plates with the bacterial
strains bearing plasmids with the indicated Gst-APN1 fusion genes. The bottom layer
of the gradient plate contained either 0.025 mrnol of MMS (A) or 1.17 mM of 1’2O2
(B). Growth along the gradient is considered to be 100%. Pictures were taken afier
incubation for 24 h at 37°C.
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O Figure 2-6. Comparison of the DNA repair activities ofApnl ami the mutantforms, E15$G and D192G.
(A) Analysis of the AP endonuclease activity. The 5-32P-labeled 42-mer double
stranded oligonucleotide U’G substrate (40 nM) containing a single AP site at
position 21 was treated with uracil DNA glycosylase to create an AP site, and then
the AP endonuclease assay was carried out in a reaction volume of 10 tL at 37°C for
20 min with the following concentration of purifled proteins: lanes 1 and 2, 3 and 6
ng of Gst-Apnl, respectively; lanes 3 and 4, 10 and 20 ng of Gst-Apnl(E158G),
respectively; and lanes 5 and 6, 10 and 20 ng of Gst-Apnl(D192G), respectively.
Purified endo IV (9 ng) was used as a positive control. Formation of the 20-mer AP
endonuclease incision product was monitored by autoradiography following
resolution on a 10% polyacrylamide (19:1 acrylamide:bisacrylamide ratio)-7 M urea
sequencing gel. Arrows indicate positions of the 42-mer substrate and the 20-mer
product. (B) Analysis of the 3-diesterase activity. The labeled 42-mer double
stranded oligonucleotide AP site substrate xvas pretreated with excess purified
endonuclease III to create the 20-mer product bearing the 3’-Œ, J3-unsaturated
aldehyde. Processing of this blocked end with 3’-diesterase activity creates a faster
migrating 3’-hydroxyl group. The 3-diesterase activity was performed in a reaction
volume of 10 jiL reaction at 37°C for 20 min with the same protein concentrations
given for panel A. Purified endo IV (4 ng) was used as a control to cleave the AP site
substrate and to reveal the position of the 3’-hydroxyl group. Arrows on the right
indicate positions of the Y-a, -unsaturated aldehyde and 3’-hydroxyl group. (C)
Analysis of the incision activity on substrates containing oxidized bases. The 5’-32P-
labeled duplex oligonucleotide substrates containing dHU/G (20 nM, lanes 1-5),
dHT/A (20 mM, lanes 6-10), or THF/G (10 nM, lanes 11-15) were incubated with
Apnl (lanes 2, 7, and 12), Gst-Apnl (lanes 3, 8, and 13), E158G (lanes 4, 9, and 14).
and D 192G (lanes 5, 10, and 15) under the same reaction conditions given for panel
A. Control lanes 1 and 6 contained substrates that were treated with light piperidine.
Arrows indicate the positions of the 30-mer substrates and the 10-mer product. The
data is representative oftwo independent analyses.
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Q We further note that the 3’- to 5’-exonuclease activity is unlikely to be the resuit of abacterial contaminant that is copurified with Gst-Apnl, as this activity was flot
detected with the mutant when incubated with the endo IV pre-incised A? site (data
flot shown). These data suggest that Apnl may possess a 3’- to 5’-exonuclease activity
(see the Discussion).
Analysis of the Gst-Apnl(E158G) mutant revealed that it was highly
inefficient at cleaving the AP site substrate (Figure 2-6A, lane 4 vs lane 2). In
separate experiments. we estimated that the Gst-Apnl(E 158G) mutant exhibited a
nearly I 50-fold reduction in AP endonuclease activity, compared to that of the native
Gst-Apnl (data flot shown). In contrast, the Gst-Apnl(D192G) mutant exhibited no
detectable cleavage activity even at protein concentrations in excess of 200-fold
(Figure 2-6A, lane 6 vs lane 2, and data not shown). These findings clearly indicate
that the glycine amino acid substitution at either position 158 or 192 dramatically
reduces or completely abolishes the AP endonuclease activity of Apnl, respectively,
such that the resulting mutant proteins cannot repair MMS-induced AP sites in the
(f DNA repair deficient strains.
We next monitored the 3’-diesterase activity ofthese proteins by following the
removal of a 3’-blocking DNA lesion, 3’-a,fl-unsaturated aldehyde. To create this
lesion, the 42-mer oligonucleotide substrate containing the AP site was pretreated
with the A? lyase endonuclease III, which cleaves the AP site by a fl-elimination
reaction 3’ to the AP site, to generate the 20-mer product containing, at the 3-end,
trans-4-hydroxy-2-pentenal-5-phosphate (3 ‘-a,/?-unsaturated aldehyde) (Figure 2-
6B). This endonuclease III preparation is contarninated with Fpg, an enzyme that can
cleave AP sites to generate a 3’—phosphate (Figure 2-6B). Thus, the /rans-4-hydroxy-
2-pentenal-5-phosphate (3’-u,fl unsaturated aldehyde) product also contained a minor
amount of 3’—phosphate (Figure 2-6B). Both the 3’-Œ,fi unsaturated aldehyde and the
3—phosphate can be removed by a 3’-diesterase activity to create the intermediate
migrating 20-mer containing a 3’-hydroxyl group (Figure 2-6B). As shown in figure
2-6B, the native Gst-Apnl actively processed the 3’-a,fl-unsaturated aldehyde and the
3—phosphate to generate the 20-mer product bearing the 3’-hydroxyl group, which
( migrated to the same position as the product produced by direct AP endonuclease
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4 action, such as endonuclease IV on the 42-mer AP site substrate. In contrast, neither
of the Gst-Apnl mutants was capable of rernoving the Y-blocking groups (Figure 2-
6B, lane 3 or 4, and lane 5 or 6). Thus, substitution of the amino acid residues E 158
and D192 ofApnl with glycine abolishes the 3-diesterase activity ofthis enzyme.
In addition to AP endonuclease and 3’-diesterase activities, Apnl also
possesses the ability to incise DNA at the site of oxidatively damaged bases, e.g., 5,6-
dihydropyrimidines, that are the major products generated by y-irradiation under
anoxic conditions [84]. We therefore determined if this novel enzyrnatic activity of
Apnl was also altered by glycine substitutions at either E15$ or D192. We used two
independent substrates bearing either dihydrouracil paired with G (UHU/G) or
dihydrothymidine paired with A (dHT!A). A third substrate bearing a modified AP
site tetrahydrofuran (THF/G) was used as a control for AP endonuclease activity.
Cleavage of these substrates can be monitored by the appearance of a 10-mer product
on 20% denaturing polyacrylamide gels. Figure 2-6C revealed that the Gst-Apnl
mutants were unable to cleave the 5’-32P-labeled dHU/G (lanes 4 and 5), dHT/A
( (lanes 9 and 10), and TFH/G substrates (lanes 14 and 15). In control experiments,
cleavage of the DNA substrates with the purified Gst-Apnl was as proficient as the
untagged native Apnl (Figure 2-6C lane 3 vs lane 2. lane 8 vs lane 7, and lane 13 vs
lane 12). It is noteworthy that the 5,6-dihydropyrimidines, having lost their aromatic
structure, are more susceptible to base loss. As shown in Figure 2-6C when the
dflU/G- and dHT/A-containing oligonucleotides in the absence of enzyme are treated
with piperidine, they are only minimally incised (<3%), suggesting that the AP site
yield is negligible. Similar results were obtained when using Y-[32P]-dCMP labeled
dHU/G, dHT/A, and TFH/G substrates (data not shown). On the basis of the findings
described above, we conclude that glycine substitution at either E15$ or D192 of
Apnl produces variant proteins with severe defects in their ability to process DNA
lesions.
Gst-Apnl mutants bind to double stranded otigonucleotide
We next exarnined if the DNA repair defects of the Apnl mutants could be a
( consequence of an inability to bind DNA. We thus monitored the binding of the
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purified proteins to two different double-stranded 42-mer oligonucleotides using an
electrophoretic mobility shift assay (EM$A). One of the 42-mer double-stranded
oligonucleotides contained a natural DNA sequence, and the other carried a central
UG mispair. Like the native Gst-Apnl, the two mutants retained the ability to bind
the natural 42-mer oligonucleotide (Figure 2-7A, lanes 2 and 3 vs lane 1), as welt as
the 42-mer oligonucleotide carrying the U•G mispair (Figure 2-7A, lanes 7 and 8 vs
lane 6). Tn addition, binding of the native Gst-Apnl and the two mutants to the
labeled 42-mer oligonucleotide was dependent on protein concentration (Figure 2-
7B). Moreover, no difference in elution profile was observed between the native Gst
Apnl and the mutants upon chromatography on double-stranded DNA agarose
column (data not shown). These data suggest that neither ofthe two single-arnino acid
changes alters the ability of the protein to bind DNA. h is noteworthy that under
identical conditions of the assay, when the native Gst-Apn 1 bound to the UG mispair
42-mer DNA, but flot the native 42-mer DNA, it consistently showed a slower
migration complex (Figure 2-7, lane 6 vs lane 1). However, this siower migration
pattem was not observed with either of the two mutants (Figure 2-7, lanes 7 and 8).
This phenomenon could be related to the mechanism by which members of the Endo
IV family are proposed to recognize and bend the DNA at the site of the lesion (see
the Discussion).
ç
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Figure 2-7. Mobility-shift analysis of a natural and a mismatch-containing 42-
mer-Iabelled double stranded oligonucleotide by purified Gst-Apnl, Gst
Apnl(E158G), Gst-Apnl (11192G), and Gst.
(A) Binding of a fixed amount of purified proteins to the 42-mer labeled
oligonucleotides. The purified proteins (5 ng) were incubated with 0.1 ng of 5’-32P-
labeled 42-mer double-stranded otigonucleotide (1.5 x cpm), either the normal
(CG. lanes 1-4) or the mismatched (UG, lanes 5-8), in 10 tL buffer B for 20 min at
room temperature (sec Materials and Methods). The protein-DNA complexes were
resolved on a 6% native polyacrylamide (1 9:1 acrylamide:bisacrylamide ratio) gel by
electrophoresis in a high-ionic strength Tris-glycine buffer, and the protein-DNA
complexes were revealed by autoradiography. (B) Binding of increasing amounts of
purified proteins to the 42-mer labeled (UG) oligonucleotide: lane 1, free probe, and
no protein; lanes 2-4, 10, 20, and 40 ng of purified Gst, respectiveÏy; lanes 5-7, 10,
20, and 40 ng of purified Gst-Apnl, respectively; lanes 8-10, io, 20, and 30 ng of
purified Gst-Apnl(EY5SG), respectively; and lanes 11-13, 5, 10, and 40 ng ofpurified
Gst-Apn 1 (D 192G), respectively.
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( DISCUSSION
In this study, we created two variants of the DNA repair enzyme Apnl from
the yeast S. cerevisiae by replacing either the glutamate or aspartate amino acid
residue at positions 158 and 192, respectively, with glycine. We show that the
resulting mutants E 158G and D 192G have no apparent defects in protein stability or
in the abiiity to enter the nucleus or to interact with DNA. However, these variant
proteins were unabie to restore resistance to MMS and J-1202 to a DNA repair
deficient yeast strain, strongly suggesting that E15$ or D192 is required for Apnl to
repair damaged DNA in vivo. In strong support of this, the purified mutant proteins
were found to be either severely or completely deficient in Apnl-associated DNA
repair activities including AP endonuclease and 3-diesterase, as well as the incision
of oxidized bases [78,84,136]. The fact that a single-arnino acid change sharply
diminishes ail the DNA processing activities of Apnl strongly suggests that the
different enzymatic activities ofthis protein are govemed by the same active site. It is
therefore possible that the amino acid residues E15$ and D192 play crucial role(s) in
C the enzyme catalytic center. In addition, it would appear that the function of D192 is
more critical than that of E158, as the D192G substitution showed no residual
enzymatic activities as compared to E158G which showed 15O-fold reduction.
Recently, the high-resolution atomic structure of E. cou endo IV was
determined when the enzyme is bound to a 1 5-mer duplex DNA containing a
synthetic AP site [67]. The crystal structure provided clear insight into the enzyme
catalytic mechanism and revealed that endo IV consists of eight parallel fl-strands
each surrounded by peripheral Œ-heiices in forming an a88 TIM barrel fold, which is
suitably arranged to bind DNA [67]. At AP sites, the enzyme acts by compressing and
bending the DNA 9O0 such that it causes the orphan nucieotide and the AP site to
flip Dut of the duplex [67]. The AP site is then sequestered within an enzyme active
site pocket, where the 5’-phosphate bond is cieaved by a trinuclear zinc cluster that
renders the phosphorus atom susceptible to a nucleophilic attack [67]. The endo IV
enzyme pocket has the abiiity to discriminate between undamaged and damaged
nucleotides [67]. The undamaged nucleotides exist in a /3-configuration and are
( sterically excluded from the enzyme active site pocket [67]. However, damaged
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nucleotides with an Œ-configuration, such as dihydropyrimidines, 5-
hydroxypyrimidines, and formamidopyrimidines can be accomrnodated by the
enzyme active site pocket, providing a reasonable explanation why members of the
endo IV family can directly incise DNA containing oxidatively damaged bases
[$4,1481. In addition. the endo IV enzyme pocket is stnictured to accommodate strand
breaks terminated with 3’-blocking groups such as 3-phosphate and a, 16-unsaturated
aldehyde [67]. Thus, the structural and functional conservation that exist between
endo IV and Apnl strongly suggest that Apnl is likeÏy to use a similar enzyme active
site pocket to process DNA lesions. However, this might flot be the case, as our
structure-function analyses revealed some key differences between endo IV and
Apnl. PreviousÏy, we have established that a mutant forrn of endo IV, E 145G, was
unable to bind to DNA [139]. Consistent with our findings, the high-resolution
structure of endo IV reveated that F145 indeed lies within one of the five DNA
recognition loops, which the enzyme uses to make contact with double-stranded DNA
[67]. Surprisingly, a glycine substitution ofthe identical amino acid residue E158 in
( Apnl did flot prevent this mutant from binding to double-stranded DNA, suggesting
that E158 may play a single role perhaps making contact only with the metat ions
required for catalysis, while the endo 1V F145 residue plays a dual role in DNA
binding and coordinating the trinuclear Zn cluster [67,13 91.
Another key difference between Apnl and endo IV lies within one of the most
conserved stretch of amino acid residues (‘75GVCIDTCH’82) shared by the Endo IV
family. In this region, replacement of the aspartate with glycine (D 179G) reduces
endo IV enzymatic activities by nearly 40-fold [139]. According to the endo IV
crystal structure, Aspi 79 residue plays a role by stabilizing the positions of two of the
three Zn (Zn2 and Zn3) atoms within the trinuclear Zn cluster required for the
enzyme catalytic reaction [67]. In the case ofApnl, we found that the corresponding
Aspi 92 residue showed no residual enzymatic activities. It is unlikely that differences
in the Zn atom content can account for the disparity in the enzyme level of the endo
IV and Apnl mutants. as atomic absorption spectrometry revealed that Apnl also
contains at least three Zn atoms [149]. A reasonable explanation would be provided if
one ofthe Zn atoms ofApnl is only weakly held in the active site pocket by Asp192,
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as compared to endo IV where the Zn atoms are held in place by the side chains of
multiple amino acid residues. In fact, Apnl treated with the metal chelator, 1,10-
phenanthroline can be reactivated by addition of ZnC12, but flot endo IV treated in a
similar maimer [149]. If indeed Asp192 forms a metal ligand, it is likely that the
D 192G mutant could have a lower Zn content, although addition of ZnCÏ2 did not
reactivate either the EI58G or the D 192G Apnl mutant (data not shown). We
anticipate that crystallographic studies of this D 192G mutant of Apn 1 in the presence
of duplex DNA bearing an AP site should clearly define the role of this important
amino acid residue.
We believe that the native Gst-Apnl purified from E. cou may possess an
intrinsic 3’- to 5’-exonuclease activity, which removes additional nucleotides
following cleavage of the AP site. In fact, a recent study also documented that Gst
Apnl purifled from yeast can remove additional nucleotide(s) in the 3’- to 5’ direction
at a nick in double-stranded DNA to create a gap. although removal of the first
nucleotide appears to be more rapid [85]. If indeed the 3’- to 5’-exonuclease activity is
an inherent property of Apnl, as recently demonstrated for endo IV [150], then this
activity could be regulated perhaps through protein-protein interaction as observed for
Apn2 [93], and play an important ftinction in maintaining the fidelity of DNA
polymerase by removing incorrectly incorporated bases.
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ABSTRACT
Reactive oxygen species can attack the mitochondrial genome to produce a
vast array of oxidative DNA lesions including 8-oxo-7,$-dihydro-2’-deoxyguanosine
(8-oxo-dGuo). We assess the role of the Saccharomyces cerevisiae 8-oxo-dGuo DNA
glycosylase, Oggi, in the maintenance of a poly(GT) tract reporter system present in
the mitochondrial genome. Deletion in the poly(GT) tract causes the reporter system
to produce arginine-independent (Arg) colonies. We show that the mitochondrial
form of Oggi is functionally active at processing 8-oxo-dGuo lesions and that Oggi
deficient celis exhibit nearly 5-fold elevated rate of Arg mutants under normal
growth condition, as compared to the parent. Overexpression of Oggi completely
suppressed the high rate of Arg mutations to levels lower than the parental,
suggesting that Oggi function could be limited in the mitochondria. Further analysis
revealed that the Arg mutations can be prevented if the ceils are grown under
anaerobic conditions. These findings provide in vivo evidence that oxidative stress
induces the formation of lesions, most likely 8-oxo-dGuo, which must be repaired by
Oggi, otherwise the lesions can trigger poly(GT) tract instability in the mitochondrial
genome. We also demonstrate that overproduction of the major apurinic/apyrimidinic
(AP) endonuclease ApnÏ, a nuclear and mitochondrial enzyme with multiple DNA
repair activities, substantially elevated the rate of Arg mutants, but which was
counteracted by Oggi overexpression. We suggest that Oggi might bind to AP sites
and protect this lesion from the spurious action of Apnl overproduction. Thus,
cleavage of AP site located within or in the vicinity of the poly(GT) tract cotild
destabilize this repeat.
Keywords: DNA repair enzymes, repeat sequences, yeast, mitochondria, genetic
instability
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INTRODUCTION
Haploid ceils of the budding yeast Saccharornyces cerevisiae consist of nearly
50 copies of the mitochondrial genome (mtDNA), which is 75-$5 kb in size and
82% rich in AI sequences, and mainly encodes subunits of the electron transport
system, as weIl as RNAs for assembling the mitochondriat transiational machinery
[151,152]. The mtDNA is constantly exposed to endogenous reactive oxygen species
(ROS) produced, for example, during the four-electron reduction of oxygen to water
in the oxidative phosphorylation process. It is estimated that each mitochondrion
produce 10 x 106 ROS molecules per ceil per day [153,154]. These ROS can damage
the mtDNA to generate a repertoire of 70 known modifications, including isomers, of
which 8-oxo-dGuo is a major lesion that can lead to G to T transversion mutations
[155]. In fact, the mtDNA accumulate mutations one order of magnitude greater than
that of the nuclear DNA. consistent with the vulnerability of the mitochondria to
ROS-induced DNA damage [156,157]. In mammalian ceils, the mtDNA is
continuously replicated even in terminally differentiated celis such as nerve celis
[158]. Thus, somatic mtDNA mutations are likely to cause severe effects on cellular
ftmnction, as well as being involved in the pathogenesis of a variety of diseases
including cancer and degenerative diseases such as Parkinson’s, Alzheimer’s, and
Huntington’ s [159-162].
To date, several DNA repair enzymes have been found in the mitochondria
that contribute to the maintenance of mtDNA integrity [82,163-165]. for example,
inactivation of S. cerevisiae Oggl, an enzyme that repairs 8-oxo-dGuo, leads to
increased frequency of mitochondrial petite mutants due to deletions in the mtDNA
[166]. However, these Oggi-deficient celis do not appear to exhibit elevated point
mutations in the large ribosomal RNA gene (21S rRNA) that give Tise to
erythrornycin resistant colonies [166,167]. Thus, it would appear that unrepaired 8-
oxo-dGuo lesions rnight cause deletions rather than base substitutions in the
mitochondrial genome. In this study, we set out to investigate if Ogg 1 -deficiency
would interfere with the stability of poly(GT) tracts installed within the mitochondrial
genome. Essentially, the poly(GT) tract serves as a sensitive reporter system
( consisting of a derivative ARG8m that functions as a mitochondrial gene, instead of a
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Q nuclear gene, and encoding an enzyme (acetylomithine aminotransferase) of thearginine biosynthetic pathway [168-170]. The derivative ARG8m gene contains either
poly(GT) or poly(AT) tracts creating +1 or +2 frameshifis causing the ceils to become
phenotypically Arg [170]. Alterations in the poly(GT) or poly(AT) tracts restore the
reading frame of the arg8rn alleles to give rise to Arg colonies [170]. For this study,
we exploited onÏy the poly(GT) tract with +2 frameshifi as it is 25-fold more unstable
in the mtDNA, undergoing a rate of 40 xl 0 changes in the tract per ccli division
when compared to the poly(AT) tracts, which changes at a rate of—1.6 x107 per celi
division [170]. Using this system, we show that Oggi-deficient ceils exhibit nearly
six-fold elevated rate of Arg mutants, as compared to the parent. These Arg mutants
were completely suppressed by overexpression of the Oggi enzyme, suggesting that
unrepaired $-oxo-dGuo Ïesions can trigger instability of GT tract repeats in the
mitochondrial genorne. Interestingly, overproduction of the major
apurinic/apyrimidinic (AP) endonuclease Apnl, a nuclear and mitochondrial enzyme
with multiple DNA repair activities including the ability to incise AP sites, did not
prevent the poly(GT) tract instability of the Oggi-deficent ceils, and instead
potentiated the destabilization resulting in higher levels of Arg mutants. However,
the Apnl-induced GT tract instability was counteracted by the simultaneous
overexpression of Oggl. Because Oggi can bind to AP sites with high affinity, we
suggest that it miglit serve to protect this lesion from the spurious action of Apnl
overproduction. Thus, cleavage of AP site within the poly(GT) tract could destabilize
the repeat.
C
69
O MATERIALS AND METHODS
Yeast strains
The S. cerevisiae strains used in this study were CAB 193 (isogenic to
DFS1$8; Mat a, ïtra3-52 leu2-3, 112, lys2 his3 arg::hisG; except carrying poly(GT)
repeat in +2 reading frame) and CAB 152 (also isogenic to DfS 18$, except carrying
poly(AT) repeat in +2 reading frarne) (kindly provided by Dr. E. Sia, University of
Rochester, New York, USA). The following isogenic strains were derived from
CAB193 and constnicted using the one-step gene targeting approach t171]. RVY6
(oggiA: :H183), RVY7 (apnlA: :LEU2), RVY$ (ntglA: :LEU2), RVY9 (oggiA: :HI$3
ntglA:.LEU2), and RVY1O (ogglA:.i-1183 apnlA:.LEU2). Yeast ceils were grown in
either complete yeast peptone dextrose (YPD) or minimal synthetic (SD) medium, to
which nutritional supplement were added at 20 tg/mL [172,1 73]. Standard genetic
analysis and transformation were carried out as described previously [172,1731. The
Escherichia cou DH5a strain was used for ptasmid maintenance.
o
Construction of the plasmid pOGG1-GFP
The plasmid pOGG1 (kindly provided by Dr. S. Boiteux. CNRS-CEA.
Fontenay aux Roses, France), which contains the entire S. cerevisiae OGGJ gene,
was used as the template to amplify by polymerase chain reaction (PCR) the entire
coding region of the OGGJ gene using the primers OGG Ï-Fi (5 -AAAGTTATTAG
ACCTGAATTCACGACTACTCATAGAAAACG-Y) and OGG1-F2 (5’-
CTATGACTTTTTAGGGGTACCTATTTTTGCTTCTTTGATG-3’) bearing the
restriction sites (underlined) for EcoRI and KpnI, respectively. This procedure yielded
a 1.6 kb fragment which was digested with EcoRI and KpnI and subcloned into the
Yeplac 195 yeast expression vector containing the GFP gene downstream of the
cloning site. Thus, the OGG] gene was ftised to the N-terminal of GFP in order to
create the plasmid pOGGI-GfP.
To obtain a higher expression level of the Ogg1-Gfp fusion protein, the
fragment containing the OGG1 gene attached to the N-terminal of GFP was amplify
C by PCR using the primers OGGI-F2
______
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Q TGTCTTATAAATTCGGC-3) and GFP-SalI (5’-AGAACTAGTCGACCCTTATT-TGTATAG-3’) bearing the restriction sites (underlined) for HindIII and SalI,
respectively. The 1.9 kb fragment was subcloned into the multicopy vector pYES2.0,
bearing the galactose-inducible promoter GAL], to produce the plasmid pYES
OGG 1 -GFP.
Preparation of mitochondrial fractions from yeast
Mitochondria! extracts were prepared from the purified organelle as
previously described [$2]. The ce!! peliets were weighed, washed with H20,
resuspended (0.3 g/mL) in 100 mM Tris-$04 (pH 9.3) buffer containing 10 mM
dithiothereito!, incubated with gent!e shaking at 30°C for 10 mi and centrifuged
3,000 x g for 5 min at room temperature. Fol!owing centrifugation, the pe!!ets were
washed once with buffer B (1.2 M D-sorbito!, 20 mM KPB [pH 7.4]), and zyrno!yase
at 2.5 mg/g of ce!! pe!!et in 0.1 g of ccli pe!!et/mL of buffer B was added. The peliets
were incubated for 60 min at 30°C with gent!e shaking unti! the ce!! wa!1 was
compietely digested. The spheroplasts werc co!!ected at 3,000 x g for 5 min at room
temperature and washed three times (1 g/10 mL of buffer B). From this point, ail
manipu!ations were performed at 4°C. The spherop!asts were suspended at 1 g/2 mL
of MIB (0.6 M D-mannito!, 20 mM HEPES-KOH [pH 7.4], 0.5 mM
phenylmethylsu!fonyl fluoride) and broken in a Dounce homogenizer with 15 strokes
using the pestie (g!ass and Teflon). The homogenate was then diluted 2-fold in MIB
and centrifuged at 3,000 x g for 5 min. The peliet contained crude nuc!ei, and the
supematant represents the crude cytop!asm and mitochondria. The supematant was
spun at 12,000 x g; the resu!ting peliet contained the crude mitochondria.
To obtain purified mitochondria, the crude mitochondria were di!uted in
200 tL of MIB and !ayered on a two-step Nycodenz (Sigma) gradient made in a 14-
by $9-min Ultra-Clear centrifuge tube. The bottom !ayer of the gradient contained
5 mL of 18% and the top !ayer contained 5 mL of 14% Nycodenz in MIB. The tubes
were spun at 40,000 x g in an 5W41 rotor for 30 mi and the purified mitochondria
were recovered between the two layers as a light brown hand. The purified
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mitochondria were diluted fivefold in MIB and centrifuged at 12,000 x g for 10 min.
Ihe resulting mitochondrial pellet was lysed by addition of 200 tiL of yeast extraction
buffer to produce the mitochondrial fraction.
Western blot
The proteins were separated on 12.5% SDS-PAGE gel, transferred onto a
nitrocellulose membrane (8 cm x 10 cm) (Amersham Life Science) which was then
blocked with buffer ISEM [10 mM Tris-HCI (pH 7.45), 150 mM NaCÏ, 0.1% Tween,
1 mM EDTA, 5% powdered milkj for 1 h. After the blocking, the membrane was
probed with 10 mL of buffer TSEM containing monoclonal Gfp antibodies at a
dilution of 1:5000 for 16 h at 4°C. Following the probing, the membrane was washed
three times for 15 min with TSEM before adding 10 mL of the anti-mouse IgG
conjugated to horseradish peroxidase at a dilution of 1:2500 (BIO/CAN Scientific
Inc., Ont., Canada) for 1 h at room temperature. Finally, the membrane was washed
again three times for 15 min with TSEM and immunoreactive polypeptides were
detected by chemiluminescence (Dupont-NEN).
Preparatïon of DNA substrate and assay for Oggi activity
A 30 base synthetic oligonucleotide containing a unique $-oxo-dGuo residue
at position 11 (5TGACTGCATA0x0 t10CATGTAGACGATGTGCAT3’) was 5!
32P-end-labeled (provided by Dr. Murat Saparbaev, France). The specific activity of
the labeled oligonucleotide was determined by running an aliquot on a 10%
polyacrylamide gel and quantitating the amount of incorporated radioactivity. The
oligonucleotide was ethanol precipitated, resuspended in TE [10 mM Tris-HC1 (pH
7.5) and 1 mM EDTA], and annealed with an equimolar amount of the
complernentary oligonucleotide (5 ‘-ATG CACATCGTCTACATGCCTATGCAG
TCA-Y) by heating at 83°C and slow-cooling to room temperature. The 8-oxo-dGuo
cleavage reactions were carried out in buffer containing 25rnM Tris-HCI (pH 7.4),
5OmM KCÏ, 2mM EDTA, 1 pmol oligonucleotide substrate, and the indicated( concentration of mitochondrial extracts or purified bacteria fpg protein in a final
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volume of 12.5 fiL. Incubation were carried out at 37°C for 30 min and stopped by
the addition of 5 pi formamide loading buffer. Samples were prepared for gel
electrophoresis by heating at 65°C for 5 min. Reaction products were analysed on
10% denaturing polyacrylamide gels.
Measurement of mutations rates of mitochondrial UNA
The rate of mutation to Arg was performed as previously described [170].
Briefly, 10 to 15 independent colonies of the indicated strains were grown in Ï mL of
SD medium supplemented with 20 tg/mL of the appropriate auxotrophic
requirements and grown at 30°C overnight in an orbital incubator shaker set at 250
rpm. The following day, the celis were centrifiiged, washed twice with sterilized
distilled water, resuspended in 1.5 mL of YPD, and incubated at 30°C with shaking
for 4 h until 0D600 reach —0.8 to 1.0. Afier centrifugation, ceils were again washed
twice with sterile water, and resuspended in 1 mL of sterile water. Serially diluted
celis (typically 100 iL ofthe 10 and 10-t dilutions) were plated on SD solid medium
plates containing arginine (for total colony count) and without arginine (for scoring
the Arg revertants), respectively. Total colonies were counted afier 2 days, while the
Arg revertants colonies were counted after 2, 5, 10, and 15 days following
incubation at 30°C. The rate of Arg revertants, which possess alterations in the
repeat tracts that restore the reporter gene reading frame, was calculated by method of
the median [174]. For the measurement of Arg revertants under anaerobic
conditions, the BBL GasPak Pouch system was used. Ceils were grown, plated as
above, and incubated in the GasPak system for 5, 10, and 15 days at 30°C.
Analysis of the Iength of mitochondrial microsatellites
The types of alterations present in the repeat tracts were determined by PCR
analysis of the ARG8’° as previously described [170]. The length ofthe poly(GT) tract
without deletion is $8 nucleotides [170].
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Analysis of 8-oxo-dGuo in mtDNA by HPLC
Mitochondrial DNA (mtDNA) was separated according to the protocol in
“basic methods of yeast genetics” [175]. Briefly, celis were suspended in 0.9 M
sorbitol and 0.1 EDTA (pH 7.5), treated with 7.5 mg/mL of Zymolyase 20 000 and
incubated at 37°C for 70 min. The ceils were lysed in 50 mM Tris-HC1 (pH 7.4), 20
mM EDTA with 10% SDS. The nuclear and mitochondrial fractions were then
separated by two cycles of differential centrifugation (2000 x g for nuclei followed by
10,000 x g for mitochondria). mtDNA was purified by the mtDNA Extractor CT kit
(291-55301) according to the recommended protocol (Wako Chemicals USA, Inc.,
Richmond, VA). The yield of purified mtDNA varied from 2 to 5 tg for samples
containing 50 tg of crude mtDNA (4-10%). Purified mtDNA (40-50 tg) was
dissolved in 50 tL of freshly drawn nanopure water (Millipore, Bedford, MA). The
sample was incubated for 20 min at 40°C with nuclease P1 [5 tL; 1 unit/pL in acetate
buffer 50 mM (pH 4.8)], and then for another 40 min at 40°C with alkaline
phosphatase [5 iL of alkaline phosphatase; 1 unit4tL in 50 mM Tris-HC1 buffer (pH
7.4) plus 7 LL of 1.2 M ammonium acetate (pH 7.0)]. The mixture ofnucleosides was
acidified (pH 4) by addition of 5 pi of 0.22 M phosphoric acid, and then extracted
with 50 tL of chloroform by brief vortexing and centrifugation at 13 200 x g for 5
min to eliminate excess proteins. The aqueous phase was recovered and transfened to
150 tL plastic vials for HPLC analysis. Analysis of 8-oxo-7,8-dihydro-2’-
deoxyguanosine (8-oxo-dGuo) by HPLC was carried out using a Model 2690
Alliance system (Waters, Milford, MA) connected to a Model 2487 UV detector
(Waters) and a Coulochem II electrochemical detector (ESA Associates, Chelmsford,
MA) equipped with a Model 5011 analytical ceIl (ESA Associates). Nucleosides were
separated on a ODS-A, 250 mm x 6 mm, 5 tm particle size analytical octadecylsilyl
column (YMC, Kyoto, Japan) coimected to a Model CH-30 Eppendorf column heater
set at 30°C (Hamburg, Germany) with 8% methanol in 50 mM phosphate buffer at
pH 5.0 as the mobile phase at a flow rate of 1 mL/min. For optimal detection of 8-
oxo-dGuo, the first and second electrodes of the electrochemical cell were set at 250
and 450 mV, respectively (voltage versus Pd reference electrode). The amount of
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damage (8-oxo-dGuo/ 106 dGuo) was estimated from the ratio of peak areas for 8-
— oxo-dGuo, obtained by electrochemical detection, and non-modified 2’-
deoxyguanosine (dGuo), obtained by UV detection, during the same chromatographic
run.
C
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RESULTS
The mitochondrial form of Oggi is active at processÏng 8-oxo-dGuo Jesions
Previously, it was shown that a GFP tagged form of Ogg 1 can be distributed
to the mitochondria of yeast celis, although this report did flot monitor for the enzyme
activity in this organelle [166]. To examine if Oggl is enzymatically active in the
mitochondria, we deleted the OGG] gene in the parent strain CAB 193 to produce the
oggiA mutant strain RVY6 and examined the purified mitochondria derived from
these strains for Oggi activity. To monitor the activity of Oggi, we used a 30-mer
double-stranded oligonucleotide bearing a single 8-oxo-dGuo lesion at position 11 in
the upper strand [22,176]. As shown in Figure 3-1, extract derived from the purified
mitochondria obtained from the parent strain cleaved the 30-mer substrate to produce
the expected 10-mer product (lanes 5 and 6), similar to the product generated by
purified fpg protein (lane 2), the bacterial counterpart of the yeast Oggl [176]. In
contrast, extracts derived from purified mitochondria obtained from the ogg]A nuil
mutant showed no detectable cleavage of the substrate even at the highest
Ç concentration of mitochondrial extract used in the assay (Figure 3-1, fane 10). On the
basis of our findings, we conclude that Oggl is indeed present in the mitochondria, as
previously reported [166], and in an enzymatically active form. In control experiment,
mitochondrial extracts derived from either the parent or the ogg]A mutant equally
cleaved an abasic site substrate [$2] (data not shown), suggesting that the absence of
Oggl is unlikeÏy to cause alteration in the levels of other base excision repair
enzymes.
ogglA mutants exhibit elevated poly(GT) tract instabîlity
We next tested if Ogg 1 is required for maintenance of poly(GT) or poly(AT)
tract stability. To do this, we exploited the parent and oggiA nuil strains carrying the
derivative arg8” alleles with +2 frameshift mutations created by the insertion of
either a poly(GT) or a poly(AT) tract [170]. These strains are unable to grow on
medium lacking arginine, unless a 2-bp deletion occurs in the GT or AT tract to(
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Figure 3-1. Mitochondrial Oggi is functionally active.
Oggi assay was carried out with the following concentrations of the purified
mitochondrial extracts prepared either from the parent strain CABY93 (lanes 3-6) or
the oggM mutant (lanes 7-10); 0 (lanes 3 and 7), 20 (lanes 5 and 9), and 60 tg (lanes
6 and 10). Purified fpg 100 ng (lane 2) was used as a positive control. Arrows indicate
position of the 30-mer substrate and the 11-mer product. The data is representative of
two independent experiments.
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restore the ARG8m reading frame thereby reverting the ceils to the Arg phenotype
[170]. As shown in figure 3-2, following 2-5 days of selection of multiple
independent cultures on minimal medium plate lacking arginine, both the parent and
the oggiA mutant carrying the poly(GT) tract generated Arg revertants at the same
rate. However, afier 10 days of selection the rate of Arg mutations increased vcry
rnodestly (and no significant increased by 15 days) for the parent, while that of the
ogg]Li nuil mutant increased nearly 3-fold by 10 days and a further 3.5-fold by 15
days (figure 3-2). No significant increase in Arg mutations was observed afier 20
days of selection at which point the experiment was terminated (Figure 3-2). In the
case of the parent and the oggiA mutant carrying the poly(AT) tract, there was no
significant differences in the rate of Arg revertants, even afier 15 days of selection
(data not shown). On the basis of these finding, it would appear that Oggi is required
to suppress the poly(GT), but flot the poly(AT), tract instability.
To confirm that the poiy(GT) tract instability is a result of Oggl deficiency, we
examined the rate of Arg revertants produced by the ogg]A mutant carrying a
C. multicopy plasmid pOGGI overexpresslng the Oggi protein [176]. As shown in
Figure 3-2, plasmid pOGG1 completely abolished the high levels of Arg revertants
in the ogg]A mutant. Moreover, Oggi overexpression further reduced the level of
Arg revertants (nearly 1 .5-fold lower), as compared to the level observed in the
parent strain carrying only the ernpty vector (figure 3-2). Introduction of pOGG1 in
the parent also reduced the basal level of Arg revertants, suggesting that Oggi
function might be limiting in the mitochondria. Consistent with our findings, Singh et
aÏ. [166] showed that overexpression of cither yeast Ogg 1 or human Ogg 1 in a parent
yeast strain or the isogenic oggiA mutant further decreased the formation of petite
colonies to levels lower than that observed in the parent strain carrying only a vector.
It is noteworthy that plasmid pOGG1 did not completely eliminate ail the Arg
revertants in either the parent or oggiA mutant, suggesting that other factors might be
limiting which could contribute to the poly(GT) tract stability.
C
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figure 3-2. Oggi is requîred to maintain poly(GT) tract stability.
The rate of mutation to Arg was performed as previously described (see the
Materials and Methods). Briefly, 10-15 independent colonies of the parent strain
CAB 193 (open circles), the ogg]zl nuli mutant (filled circles), the parent with the
plasmid pOGG1 (open squares), and the ogg]A nuil mutant with pOGG1 (filled
squares) were analyzed for Arg revertants. These colonies were scored afier 2, 5, 10,
15, and 20 days on solid medium plates without arginine. Day 2 represents the
spontaneous Arg mutants arising from the overnight culture (see Table III-I). The
data is the average ofthree independent experiments.
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Since Oggi is known to repair the mutagenic 8-oxo-dGuo lesion, it is iikely
that accumulation of this lesion in the poly(GT) tract may cause the instability. As
such, we isolated the mtDNA from purified mitochondria and quantitatively
measured the level of 8-oxo-dGuo base using HPLC (see the Materials and Methods).
However, in three independent deterniinations, this approach failed to reveal any
significant difference in the levels of 8-oxo-dGuo between the mtDNA obtained from
the oggiA mutant (198 ± 12 lesions/ 106 G), as compared to the parent (184 ± 10
lesions/106 G) (see the Discussion).
PCR analysis of GT tract instability in the parent and the oggiA mutant
We next examined the types of alterations that occurred in the poly(GT) tract
by PCR analysis of 15 independent Arg colonies derived from both the parent and
the oggiA mutant. Ail (15/15) of the independent Arg colonies derived from the
parent contained 2-bp deletion, indicating that the poly(GT) tract give rise prirnarily
to deletions (figure 3-3 showing PCR analysis of two representative Arg colonies).
Similarly, ail (15/15) of the independent Arg colonies derived from the ogg]A
mutant contained deletions, but ofthese 7 showed 2-bp deletions and $ contained 14-
bp deletions or larger (Figure 3-3). This data suggests that in the absence of Oggi,
unrepaired 8-oxo-dGuo lesions might be the cause of the larger deletions in the
poly(GT) tract. Consistent with this notion, it lias been documented that inactivation
ofOggi causes deletion, but not complete loss ofthe mtDNA [1661.
Anaerobic condition eliminates the elevated mutations in the oggiA nuli
If indeed the increased rate of Arg revertants is due to oxidative DNA damage
caused by the production of ROS during aerobic metabolism, then we anticipate that
celis grown under anaerobic conditions should decrease the levef of Arg revertants.
To perform this experiment, the cells were grown under normai growth conditions in
liquid medium, plated onto solid medium lacking arginine, followed by incubation in
CC
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Figure 3-3. PCR analysis for poly(GT) tract instability.
Mitochondrial DNA was extracted as described in the Materials and Methods from
the parent strain CABÏ93 (lane 1), the oggiA mutant (lane 2), two Arg derivatives of
the parent (lanes 3 and 4), and two Arg revertants of the ogg]A mutant (lanes 5 and
6) strains. Following PCR amplification in the presence of labeled dATP, the
products were ran on 6% polyacrylamide gel and analyzed by autoradiography. The
lefi arrow indicates a $6 nt marker and the right arrows show the poly(GT) tract
without deletion (88 nt), and in frame deletions of-2, -5, and -20 corresponding to 86,
$3, and 6$ nt, respectively. The data are representative of two independent
experiments.
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anaerobic bags (see the Materials and Methods). Following 5, 10, and 15 days of
incubation under this condition, the parent strain showed a slightly reduced level of
Arg revertants (figure 3-4), as compared to growth under the aerobic condition
(Figure 3-2). Interestingly, the oggiA mutant behaved like the parent strain under the
anaerobic condition and displayed nearly the same level of Arg revertants (figure 3-
4). Since the ogg]A mutant showed a substantial increase in Arg revertants during
aerobic growth, but flot under the anaerobic condition, it suggests that the poly(GT)
tract instability is due to ROS-induced DNA lesions which must be processed by
Oggl.
Apnl overexpression in the oggiA mutant stimulates poly(GT) tract instability
We recently demonstrated that the major AP endonuclease Apnl in S.
cerevisiae possesses a strong 3’—5’-exonuclease activity, which is capable of
removing 8-oxo-dGuo that is derived from the oxidized dNTP pool and
C misincorporated into DNA during replication [86]. As such, we tested if
overexpression of Apnl might play a role in reducing poly(GT) tract instability in the
oggiA mutant, by preventing 8-oxo-dGuo misincorporation into the mtDNA.
Unexpectedly, introduction of a plasmid pAPN1, which overproduces Apnl [$1], in
the oggiA mutant stimulated the rate of Arg revertants by an additional two-fold
afier 10 days of selection, when compared to the mutant carrying only the empty
vector (Table III-I). This effect was not specific for the ogg]zl mutant, as introduction
ofpAPNl into the parent strain also stimulated the appearance ofArg revertants by
three- to four-fold (Table III-I). Since Apnl lias multiple enzymatic functions
including AP endonuclease, nucleotide incision, as well as 3’-5’-exonuclease activities
[86,177], it is possible that the uncontrolled action of this enzyme could lead to
increase nicking of the mitochondrial genome causing instability of the poly(GT)
tract (see the Discussion). We, therefore, tested if overexpression of Oggi could
counteract the poly(GT) tract destabilization triggered by Apnl overexpression. As
shown in Table 3-1, introduction of plasrnid pOGGY into either the parent or oggiA
C
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figure 3-4. Anacrobic conditions reduce the poly(GT) tract instability.
The same experirnental procedure as in the aerobic conditions was used to measure
Arg revertants under anaerobic growth, for the exception that BBL GasPaK Pouch
system was used to create the anaerobic conditions. Open circles represent the parent
strains and the flhled circles represent the ogg]zi mutant strain, respectively. The data
are the average ofthree independent experiments.
P3
RateofArgrevertants(xI06)
CD-N)C)
N)
-
‘L1)’I
\\-aQ)
CD
çJ
Q)
-CDøi-I.’ •-3
o
C—
o
Q
D
,-‘—.
II
Q)
LI)
CD
CD
CN
01_IIII
‘j
87
mutant overexpressing Apnl decreased by four- to six- fold, respectively, the
elevated rate of Arg revertants that was observed when the strains were only
overexpressing Apnl. From these data, we reasoned that Oggi miglit protect a
distinct lesion, e.g. AP site, within the vicinity of the poly(GT) tract from the
mutagenic action ofApnl overproduction.
Poly(GT) tract instability is not affected by NTG1 deiction
Previous studies showed that the NTGJ gene encodes a mitochondrial DNA
repair enzyme, which functions in the base excision repair pathway to process
oxidized pyrimidines and purines, e.g., 2, 6-diamino-4-hydroxy 5N-methylformamido
pyrirnidines, as well as abasic sites and 8-oxo-dGuo mispaired with adenine
[178,1 791. Mutants devoid ofNtgl display an elevated level of oxidative damage to
the mtDNA and exhibit a nearly two-fold increased in mtDNA point mutations, but
do not show the mitochondrial respiration-deficient (petite) phenotype [165]. Because
of the broad substrate specificity of Ntg 1, we tested if deletion of the NTG] gene in
the parent strain would affect the poly(GT) tract instability. As shown in Table III-I,
the resulting ntg]A mutant showed no increase in the rate of Arg revertants, as
compared to the parent strain. Moreover, oggiA mutant deleted for the NTGJ gene
also showed no further increase in Arg revertants, when compared to the oggiA
single mutant (Table III-I). These genetic data strongly indicate that DNA lesions that
are primarily repaired by the Ntgl enzyme rnight not be produced within the
poly(GT) tract.
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DISCUSSION
In this study, we investigate the role of Oggl in maintaining the stability of a
poly(GT) tract installed within the ARG8” reporter gene, that is embedded in the
mitochondrial genome [170]. We demonstrate that Ogg 1 -deficient mutants exhibit an
elevated rate of poly(GT) tract instability in a time-dependent manner, increasing to
nearly six-fold following incubation of the celis at standard growth conditions for 15
days. Several findings indicate that the poly(GT) tract destabilization is likeiy due to
the accumulation of unrepaired oxidized DNA base lesions, particularly $-oxo-dGuo.
Firstly, overexpression of Oggi, which is known to repair $-oxo-dGuo lesions,
completely abolished the elevated rate of mutations in the poly(GT) tract (Table III-I)
[180]. Secondly, anaerobic growth conditions, which greatly reduces the production
of reactive oxygen species and consequently oxidative DNA lesions, e.g., $oxo
dGuo, prevented the destabilization of the poly(GT) tract. Thirdly, the deficiency of
Ntgl, an enzyme which repairs primarily oxidized pyrimidines base lesions, did not
affect the poly(GT) tract stability [178,179]. FinalÏy, Oggl-deficiency had no
detectable effect on the stability of the poly(AT) tract.
Although the above observations present a convincing argument that the
oxidized DNA lesions are most iikely to cause the poiy(GT) tract instability is $oxo
dGuo, we were unable to demonstrate that this lesion accumulated in the mtDNA
derived from the ogg]A mutant, as compared to the parent. The levels we determined
by HPLC were almost indistinguishable being 19$ ± 12 and 184 ± 10 lesions /106 G
for the oggiA mutant and the parent, respectively. These levels are much higher than
levels recently reported for 8-oxo-dGuo in mtDNA from normal rodent tissue (1-14
lesions /106 G), although the level appears to increase in OGG1-defective animais
(about 125 lesions /106 G) [1$ 1,182]. In contrast, there is very liffle data availabie on
the levels of $-oxo-dGuo lesions present in the mitochondrial genome of yeast. Using
a similar method of analysis, one study reported leveis greater than 500 8-oxo-dGuo
lesions /106 G in the mitochondrial genome of S. cerevisiae [183]. The simiÏarity of
DNA damage for oggiA mutant and parent suggests that total DNA damage is a poor
indicator of mutagenesis in small localized poly(GT) targets. Altematively, the assay
90
for DNA damage may artificially induce damage that is above the Jevel of damage
associated with mutagenesis.
The observation that overproduction of the AP endonuclease, Apn 1, triggers
destabilization of the poly(GT) tract, but which was obliterated by the sirnultaneous
overexpression of Oggl. suggests that (ï) it is crucial to maintain the correct balance
of Apnl within the mitochondria [$2] and (ii) both Apnl and Oggi are likely
competing to recognize a lesion that lias the propensity to trigger genome instability.
We speculate that the common lesion might be spontaneous AP sites arising within or
in the vicinity of the poly(GT) tract. This is supported by the observation that human
OGGI can also bind very tightÏy to AP sites and only released from the lesions
foïlowing the recruitrnent ofthe human AP endonuclease, APEY [119,184]. As such,
yeast Oggi could possibly compete for binding to AP sites and protect a fraction of
the lesions from spurious cleavage by the uncontrolled action of the overproduced
Apnl, which could create excessive nicked DNA and consequently single stranded
gaps by the action of its Y-5’-exonuclease activity [$6]. Thus, the observation that
( deletion of the APN] gene in the oggiA mutant reduces the high rate of poly(GT)
tract instability (Table III-I) is consistent with a model whereby Apnl activity levels
must be tightly regulated in order to preserve the rntDNA integrity. Whether Apnl -
induced DNA nicks and or single stranded DNA gaps within a repeated DNA
sequence in the mitochondrial genome can interfere with the fidelity of DNA
polymerase y such that it undergoes slippage remains to be detennined.
While it has been demonstrated that deletion of the NTG] gene reduces the
frequency of petite mutants in the ogg]A mutant [166], this gene deletion does flot
appear to rescue or potentiate the poly(GT) tract instability in the oggiA mutant. The
mechanism by which Ntgl-deficiency prevents petite mutations in the oggiA mutant
is not known, although ntg]A single mutants do not exhibit the petite plienotype
[166]. However, the Ntg 1 enzyme can act on a variety of DNA lesions including
dihyrouracil, dihyrothymidine, 5-hydroxyuracil, fapy G, and abasic site [1 85], and it
is, therefore, possible that minimizing incision of the spontaneously damaged sites in
the mtDNA could prevent deletion in the genome that causes the petite phenotypes
ç [166]. This phenornenon has been previously documented for the inag]ziapnlA
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double mutant, whereby deletion ofthe MAGÏ gene, encoding 3-methyadenine-DNA-
glycosylase, reduces the load of the mutagenic AP sites in the apn]A mutant
[186,187]. Since in our experirnents Ntgl deficiency did not prevent the poly(GT)
tract instability in the oggiA mutant, it may suggest that Ntgl -repairable lesions are
not likely present in this repeated sequence possibility due to the small target size.
So far, the only other gene known to play an important role in the
maintenance of the poly(GT) tract stability is MSHJ, which encodes the yeast
homolog Mshl of the bacterial MutS protein [170]. Mshl is also important to
maintain the overali integrity of the mtDNA, as insh]A mutants loss mtDNA within
20 generations [18$]. The precise mechanism by which Mshl prevents genome
instability is flot known, although it is believed to serve a ftinction to recognize DNA
mismatches [170]. $tudies performed in yeast indicated that the Msh 1 homologs,
Msh2 and Msh6, are required to remove adenine mispaired with 8-oxo-dGuo in order
to prevent the incidence of $-oxo-dGuo induced G to T transversion mutations [189].
Moreover. Msh2 acts in a synergistic manner with Oggi to avoid G to T mutations
[190]. It is noteworthy that these Mshl bornologs exist as complexes (Msh2-Msh3
and Msh2-Msh6) to repair DNA mismatches and ioop structures [191]. However, no
partner has emerged yet for Mshl and raises the question as to how this protein rnight
prevent poly(GT) tract instability. Whether Mshl serves to recognize a multitude of
DNA distortions in the mtDNA including DNA mismatches, loop structures, as well
as $-oxo-dGuo lesions, and recruit the corresponding DNA repair proteins remains a
challenging task to be investigated.
In short, we found that the poly(GT) tract reporter system can be a usefril
assay to study the contribution of DNA repair enzymes in the repair of oxidative
DNA damage. This system might be amenable to examine the role of these DNA
repair proteins on other types of repeat, such as the triple (CAG) repeat involved in
Huntington’s disease [192].
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O ABSTRACT
The glycolytic enzyme giyceraidehyde-3-phosphate dehydrogenase (GAPDH)
has been implicated in many biologicai processes including its foie as a ceiiular
sensor ofoxidative stress. We show that GAPDH physicaliy associates with APE1, an
enzyme invoived in DNA repair, as well as redox regulation of several transcriptional
factors. This interaction allows GAPDH to convert the oxidized forms of APE1 to the
reduced foi-m, resulting in reactivation of AP endonuciease activity. Whiie three
GAPDH variants, C 152G, C 156G, and C247G, retain the abiiity to interact with
APE1, only C247G could reactivate the oxidized APE1 suggesting that Cys 152 and
Cys156 of GAPDH are indispensabie for APE1 reactivation. Interestingiy,
overproduction of GAPDH confers upon DLD-1 ceils additional resistance
specificaily to DNA damaging agents, which generate iesions that are repaired by
APE1. In contrast, GAPDH-siRNA knockdown sensitized the ceils to these agents.
Our data provide compelling evidence that the nuclear transiocation of GAPDH
during oxidative stress constitutes a protective mechanism involving the activation of
(
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INTRODUCTION
The evolutionary conserved enzyme glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) catalyzes a critical reaction in the second stage of the
glycolytic pathway [193]. It uses the oxidized form of nicotinamide adenine
dinucleotide (NAD+) and converts glyceraÏdehyde-3-phosphate to 1,3-
bisphosphoglycerate, which eventually generates lactate and the production of an
ATP molecule. Recent studies have documented that GAPDH is also involved in
several other biological processes that include cellular response to DNA damage
(DNA repair and replication) [194,195], tRNA export [196,197], apoptosis [198], as
weIl as histone H2B gene expression [199].
The implication of GAPDU in DNA damage response may be predicted based
on several compelling evidences. First, GAPDH transiocates from the cytoplasm to
the nucleus upon induction of oxidative stress by H202 [200]. Second, exposure to
F1202 reduces significantly GAPDH glycolytic (or dehydrogenase) activity thus
endowing GAPDH with the ability to interact with some proteins [201]. Finally.
( GAPDH was found associated with a novel protein complex distinct from rnistmatch
repair protein complexes, following its nuclear transiocation upon treatment with
mercaptopurine, an agent used for treating acute lymphoblastic leukemia. Ibis protein
complex containing GAPDH binds directly to thioguanylated DNA [202]. Together,
these data strongly indicate that GAPDH acts as an intracellular sensor of DNA
damage.
Therefore, GAPDH is no more just a historical glycolytic enzyme but bas
become a multifunctional protein of great importance. In this paper we report another
important function of GAPDH. We have found that GAPDH interacts and reduces
APEI, a known DNA repair enzyme, which plays a crucial role, for example, in
processing spontaneous and drug-induced aptirinic/apyrimidinic (AP) sites [103].
APEY has conserved cysteines and bas been reported to reduce p53 [203], and many
transcriptional factors such as AP-1 (c-Fos and c-Jun), Nf-icB, Myb, and HIF-1Œ
[109,204,205]. APE1 is thus a dual function enzyme which can regulate the redox
state of a number of proteins and also function as a DNA repair (AP) endonuclease.
We further show that overexpression of GAPDH conferred additional resistance to
C(
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agents, for example, MMS and T12O2 that create lesions, which require processing by
APE 1. Consistent with this finding, siRNA lmockdown of GAPDH sensitizes ceils to
MMS and H202 exposure, but flot to 254 nm UV light (UVC). We propose that
GAPDH might play a key role in promoting the DNA repair functions of APE 1
during oxidative stress.
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MATERIALS AND METHODS
Bacteria strains
The E. cou strains used in this work were BW528 [A(xth-pnc), nfo] :kan]
(kindly provided by B. Weiss, Emory University, Atianta, GA) and BL21(DE3)pLys$
[dcm ornpT hsdS (rB-rnB-) gaÏ%(DE3) (pLysS Camt)] (Stratagene). Strains were
transformed with the indicated vector or plasmids (see below) by the CaC12 method
[136].
Celi culture
Human lung fibroblast (LF1) and colon carcinoma celi unes (HCT116) were
kindly provided by Dr. Elliot Drobetsky (University of Montreal, Montreal, QC), and
DLD- 1 (human colon cancer cells) stably transfected with either pGFP or pGfP
GAPDH plasrnid were generously provided by Dr. W.E. Evans (University of
Tennessee, Memphis. IN). The celis were rnaintained in flam’s F10 nutrient medium
(Sigma-Aidricli, St-Louis, MO), McCoy5A celi medium (Invitrogen, Carlsbak, CA),
or RPMI-1640 medium (BioWhittaker Inc., Waikersville, MD); supplemented with
5% caif semm or 10% fetai bovine serum; 0.1 mg/mL penicillin; and 0.1 mg/mL
streptomycin.
AP endonuclease assay
This assay was performed using a 5’-end labeled 42-mer U21G
oligonucleotide substrate as previously described [143].
Purification of a protein with associated A? endonuclease activity
Ail the purification steps were done at 4°C and an AP endonuclease assay
[143] was performed after each step of purification. Approximately 5 x 106 human
lung fibroblast ceils were broken in a Dounce homogenizer with 10 strokes using the
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pestie (glass and Teflon) in 1 mL of buffer A which consisted of 50 mM Tris-HC1
(pH 7.0), 20 mM NaCI, 10% glycerol, and protease inhibitor cocktail (Complete
Mini, EDTA-free, Roche Diagnostics GmbH). Celi extracts were centrifuged at 14
000 rpm at 4°C for 10 min and the supematants were incubated with pre-equilibrated
1.6 mL DEAE-$epharose resin (Amersham Pharmacia Biotech) in buffer A by
rotating at 4°C for 15 min. The supematants were then loaded onto a 500 uL ssDNA
agarose coturnn (Amersham Pharmacia Biotech) in buffer A. The proteins were
eluted by step gradient using 100 mM (250 uL), 200 mM (250 uL), 300 mM (250
uL), and 500 mM (360 uL) NaCI in buffer A. The AP endonuclease activity of the
eluted fractions was assayed and based on the activity as revealed by
autoradiography, fractions from 200, 300, and 500 mM NaCY elutions were pooled
(pool volume = 860 uL) and were dialysed in an Amicon Ultra Centricon (Millipore
Corp.) with buffer B [50 mM Tris-HC1 (pH 7.5), 20 mM NaCl, 0.5 mM DTT, and 0.5
mM EDTA] by repeated concentration and 10-fold dilution with buffer B four times.
The last concentration step was diluted 10-fold in buffer B and loaded onto a 200 uL
MonoQ column (Bio-Rad) pre-equilibrated in buffer B. The flow-through fraction
was dialyzed by repeated concentration and 1 0-fold dilution with buffer C [50 mM
Tris-HC1 (pH 8.0), 20 mM NaC1, 0.5 mM DTT, and 0.5 mM EDTA). The last
concentration step was diluted 10-fold with buffer C and loaded onto a 200 uL
MonoQ column (Bio-Rad) pre-equilibrated in buffer C. The flow-through fraction
was then loaded onto a 200 uL CMSepharose column (Amersham Pharmacia
Biotech) pre-equilibrated in buffer C The column was washed three times with buffer
C and eluted with 100, 200, 400, and 600 mM NaC1. The eluated proteins from 200,
400 and 600 mM NaC1 elution showed AP endonucÏease activity and were pooled
and concentrated to 25 uL and desalted by centrifugation using an Amicon Ultra
Centricon (Millipore Corp.) in buffer C. The concentrated proteins were then loaded
onto a 150 uL Mono$ colurnn (Bio-Rad) pre-equilibrated with buffer C. The colurnn
was washed three times with 300 uL buffer C and eluted with 100, 200, 400, and 600
mM NaC1 in buffer C. The AP endonuclease assay on these eluted fractions revealed
an activity in the 200 and 400 mM elution and the activity correlated with a 37 kDa
Q band on a SDS-PAGE gel.
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Protein sequencing
An analysis on 12% SDS-PAGE was performed on a preparative scale and the
37 kDa band was eut, washed with 50% acetonitrile in water and sequenced by LC
MS (Harvard Microchemistry).
Plasmïds
PCR was used to ampÏify the entire GAPDH cDNA from the plasmid template
(ATCC #$ 1 7954R), digested with BamH 1 and EcoRl, and cloned into the E. cou
expression vector pGEX-4T- 1 (Amersham Biosciences) to produce the plasmid
pGST-GAPDH. The pGST-GAPDH plasmid was used as the template to generate the
pGST-GAPDH C 152G, pGST-GAPDH C 156G, and pGST-GAPDH C247G mutant
plasmids with the QuickChange $ite-Directed Mutagenesis kit (Stratagene, La Joua,
CA).
Proteins
GST-GAPDH fusion proteins were overexpressed in E. cou BW528 strain and
purified by glutathione-Sepharose 4B mini columns (Amersham Biosciences).
Briefly, the protein extracts were loaded onto the GST affinity column pre
equilibrated with buffer A which consisted of 50 mM Tris-HC1 (pH 7.5), 100 mM
NaC1, 0.5 mM EDTA, 0.5 mM DTT, and the protease inhibitor cocktail tablets
(Complete Mini, EDTA-ftee, Roche Diagnostics GmbH). The column was then
washed three times with buffer A and eluted with 250 tL of 50 mM Tris-HC1 (pH
8.0) containing 10 mM reduced glutathione. The purified fusion protein GST
GAPDH was analyzed on an SDS-PAGE gel stained with Coomassie blue and then
was assayed for AP endonuclease activity. In the case of His6-APEY, it was
overexpressed in E. cou BL2 1 (DE3) pLysS strain and purified by TALON Metal
Affinity column (BD Biosciences) according to the instructions of the manufacturer
with slight modifications. Briefly, the protein extracts (15 mg) were loaded onto the
affinity column (0.3 mL) pre-equilibrated with binding buffer which consisted of 20
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mM Tris (pH 8.0), 500 mM NaCL, 10% glycerol, 0.01% NP-40, and the protease
inhibitor cocktail (Complete Mini. EDTA-free, Roche Diagnostics GmbH). The
binding reaction was carried out at room temperature for 20 min. Then, the colunin
was washed three times with 50 mM sodium phosphate, 300 mM NaCL and eluted
with 300 tL of elution buffer consisting of 50 mM sodium phosphate, 300 mM
NaCL, and 150 mM imidazole. Human, rabbit, chicken, porcine, and yeast GAPDH
were purchase from Sigma-Aldrich.
GAPDH assay
GAPDH glycolytic activity of purifled GST-GAPDH or commercial
preparations of GAPDH from human, rabbit, chicken, porcine, and yeast was
measured by spectrophotometric assay at 340 nm. Briefly, the assay was carried out in
0.015 M sodium pyrophosphate, 0.03 M sodium arsenate (pH 8.5) (Sigma), in the
presence of 3.5 mM DTT, 0.26 mM NAD, and 0.51 mM glyceraldehyde 3-phosphate
(Sigma). The reactionswere performed for 10 min at 25°C.
Bïnding of GST-GAPDH to ifiS-APE1 column
To analyze the GAPDH/APE1 interaction using the Talon metal affinity resin
(Clonetech), 400 pL of matrix slurry was placed in a plastic disposable 10 mL
gravity-flow column (Bio-Rad). The resin was equilibrated with 10 mL of buffer B
[50 mM sodium phosphate (pH 7.0) and 300 mM NaC1]. At least 10 cg of purified
HIS-APE 1 protein was then incubated with the resin for 30 min at room temperature
with gentie shaking. The column was washed with 30 mL of buffer B, followed by
the addition of either Ï tg of purified GST-PNKP, GST-GAPDH, GST-GAPDH
C152G, GST-GAPDH C156G. or GST-GAPDH C247G, and incubation for 1 h at
room temperature. The column was washed with 30 mL of binding buffer (see
above). Bound material was eluted with buffer B containing 150 mM imidazole and
the eluted fraction was analyzed by Western Blot.
C
102
GST pull down assays
Glutathione-$epharose 4B beads (100 tL) alone or bound to 10 ig GST
tagged protein allowed to mixed with purified N-terminal 6His-tagged APE1 (1 tg)
in 0.5 mL in buffer A and incubated for 30 min at room temperature with gentie
rotation. The beads were washed three times buffer A and an aliquot was analyzed for
bound proteins by SDS-PAGE followed by Western blots probed with either anti-HIS
or anti-GST monoclonal antibody.
Immunoprecipitation
IP was performed on whole-cell lysates prepared in lysis buffer [62.5 mM
Tris-HCY (pH 6.8), 10% glycerol, 2% $DS, and the protease inhibitor cocktail
(Complete Mini, EDTA-free, Roche Diagnostics GmbH)], and then diluted 1 0-fold
with RIPA buffer [50 mM Tris-HCI (pH 7.4), 1% NP-40, 0.25% sodium
deoxycholate, 1 mM EDTA, and 150 mM NaC1]. Following preclearing with 30 pL
of Protein G plus/A agarose beads (Santa Cruz Biotechnology, Santa Cniz, CA), 1.5
mg of total protein was incubated with anti-APE1 antibodies overnight at 4°C, and
then incubated with 50 tL of Protein G plus/A agarose beads for another 1 h at 4°C.
The beads were washed four times with RIPA buffer, and then boiÏed in 2X SDS
sample buffer. The immunoprecipitates were then subjected to $DS-PAGE and the
specific proteins were detected by immunoblotting with monoclonal anti-GAPDH
antibody (Chernicon).
Immunodetection
The antibodies used in this study were monoclonal anti-HIS (Santa Cruz) and
anti-GAPDH (Chemicon), and polyclonal anti-GST (Sigma). For Western analysis,
the antibodies were used at a dilution of 1:5000, 1:2000 and 1:5000, respectively, in
10 mM Tris-HC1 (pH 7.5), 150 mM NaC1, and 5% powdered milk [206]. Ten
milliliters of this mixture were used to probe nitrocellulose blots (8 cm x 10 cm)
overnight at 4°C. The secondary antibodies were anti-mouse for the HIS and GAPDH
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Q monoclonal antibodies and anti-rabbit for the GST antibodies. Anti-mouse and antirabbit were used at a dilution of 1:2500 and 1:5000, respectively, and detected by the
enhanced chemiluminescence system (Dupont, NEN).
Oxidation of His-APE1 protein with 11202
The His6-APE1 proteins bound to the TALON metal affinity column (BD
Biosciences) were treated with 15 mM H202 (Sigma), washed 3 times with buffer B
[50 mM sodium phosphate (pH 7.0) and 300 mM NaC1], and then eluted using buffer
B containing 150 mM imidazole. The eluted proteins were dialyzed in a SpectralPor 1
dialysis tube (MWCO 6K-8K, Spectrum) by repeated concentration and dilution with
1$ mM Tris-HC1 (pH 7.5), 48 mM NaCI for five times. The concentrations of the
proteins were estimated on a Coomassie bÏue-staincd 12% SDS-PAGE gel.
Site-directed mutagenesis
The QuickChange Site-Directed Mutagenesis kit (Stratagene) was used to
change the cysteine residues to glycine using the pGST-GAPDH plasmid as the
template. Oligonucleotides GAPDH C152G-F1 (5’-CATCAGCAATGCCTCCGG-
CACCACCAACTGCTTAGC-3’), GAPDH Cl 56G-F2 (5’-GCCTCCTGCACCA-
CCAACGGCTTAGCACCCCTGGC-3’), and GAPDH C247G-F3 (5’-
GTGGTGGACCTGACCGGCCGTCTAGAAAAACCTGCC-3’) were used to
generate the pGST-GAPDK C152G, pGST-GAPDH C156G, and pGST-GAPDH
C247G mutant plasmids, respectively. The mutations were verified by DNA sequence
analysis. Ail the above oligonucleotide primers were synthesized by Invitrogen, Life
Technologies, USA.
Chemical oxidation of GST-GAPDH
The GST-GAPDH proteins bound to the glutathione-Sepharose 4B resin
(Amersham Pharmacia Biotech) were treated with 15 mM H202 at 37°C for 10 min.
The column was then washed three times with buffer A which consisted of 50 mM
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Tris-HCI (pH 7.5), 100 mM NaCY. 0.5 mM EDTA, 0.5 mM DTT. and the protease
inhibitor cocktail tablets (Complete Mini, EDTA-free, Roche Diagnostics GmbH) and
eluted with 250 jiL of 50 mM Tris-HCÏ (pH 8.0) containing 10 mM reduced
glutathione. The eluted proteins were dialyzed in a SpectralPor 1 dialysis tube
(MWCO 6K-8K, Spectrum) by repeated concentration and dilution with 18 mM Tris
HC1 (pH 7.5), 48 mM NaCI for five times.
s1RNA-mediated GAPHU silencing
Small interfering RNA (siRNA) was used to knockdown the expression of
GAPDH. HCT1 16 cells (100 000 cells/mL/well) were seeded in 6-well plates and
transfected with 75 nM of GAPDH siRNA or the control siRNA (that has not
significant homology to any known gene sequences from mouse or human) using
lipofectamine (Invitrogen) in Opti-MEM (Invitrogen). The transfection was allowed
to proceed at 37°C for 4 h afier which the cells were incubated in 2 mL ofMcCoy5A
media containing 10% fBS for 4$ h. These transiently transfected HCT 116 cells were
subjected to different treatments as described below or harvested for Western
blotting.
Drug exposure and clonogenic assay
The washed confluent ceils were exposed to different drugs. H202 was diluted
in the medium at a final concentration of 25 mM whereas MMS was prepared as 250
mM stock solution in distilled water. All of the dnigs were dissolved in RPMI for
DLD-1 ceils whereas in McCoy5A for HCTI16 cells prior to incubation. Drug
incubation was conducted in the incomplete medium for 30 min at 37°C at a ceil
density of 2 x 106 cells/mL in 5 mL and 100 000 cell/mL in 2 mL. Afier the treatment
the celîs were rinsed with IX PBS, trypsynized, counted and plated in duplicates for
the colony forming unit assay (CFU). The cells were cultured for 14 days at 37°C
with 5% C02 in humidified atmosphere. Colonies were counted afier staining them
with methylene blue [207].
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UV irradiation
C
Ceils were irradiated with monochromatic 254 nm UV light (UVC) and UVB
at a dose rate ranging from 0-20 J/m2 and 50-200 J/m2, respectively, in iX PBS. The
celi cultures were irradiated with acute doses of either polychromatic UVB (290—3 20
nm) or monochromatic UVC at room temperature. The UVB source consisted of two
fluorescent tubes (F15T8 UVB lamp; Ultraviolet Products) generating a dose rate of 4
J/m2/s. The incident UVB was filtered by using a sheet of cellulose acetate (Kodacel
TA-407 0.0 15 in; Eastman Kodak) to virtually eliminate contaminating wavelengths
below 290 mn. In the case of UVC, ceils were irradiated with a G25T$ germicidal
lamp (Sankyo Denki) at a dose rate of 0.2 J/m2/s. UVB and UVC fluences were
measured with a Spectroline DRC lOOx digital radiometer (Spectronics, Westbury,
NY) equipped with DIX 300 and 254 sensors, respectively. It should be noted that the
UVB lamp emitted some measurable incident energy within the UVA range (320—400
nm), which could flot be eliminated. Although we caimot categorically rule out that
this UVA component exerted some effect, the total UVA output under our exposure
( conditions, i.e., 50 J/m2, was unlikely to elicit any significant biological response
given that UVA is 50,000-fold less genotoxic than UVB on a per-joule basis [20$].
Western blot
The transfected celis were harvested by trypsinization and subjected to protein
extraction by cell lysis. The supernatant was collected and the protein was quantified
by Bradford’s dye binding method with bovine serum albumin (B$A) as a standard.
Western blotting was performed to evaluate the expression of GAPDH in the
transfected ceils. $0 ‘g of the protein lysate was resolved on a 10% denaturing
polyacrylarnide gel (with 3% polyacrylamide stacking) and transferred
electrophoretically to a nitrocellulose membrane (Amersham Biosciences). Afler
blocking with 5% nonfat dry milk in TBS, the membrane was incubated with mouse
anti-GAPDH (Chemicon) for overnight at 4°C. Immunoreactive proteins were
localized with horseradish peroxidase—conj tigated secondary antibodies membrane
(Amersham Biosciences) for 1 h at room temperature. After washing with TBS, the
G106
reactants were developed using the enhanced chemiluminescence kit (Amersham
Biosciences).
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RESULTS
Purification of a Mg2tindependent AP endonuclease activity
We used total celi extracts derived from cultured LF1 human lung fibroblasts
as a source to search for a Mg2tindependent AP endonuclease(s) that could share
sirnilar enzymatic properties as those reported for members of the E. cou
endonuclease (endo) IV family [60,133]. The total human cell extracts were subjected
to six chrornatographic columns and monitored for a Mg2tindependent AP
endonuclease activity by enzymatic assay afier each step of purification (see the
Materials and Methods). The final protein purification step was achieved by a NaCl
discontinuous gradient on a MonoS column, which yielded a single polypeptide of
approximately 37 kDa as visualized by Coomassie blue staining (Figure 4-lA). No
additional polypeptide was detected in the MonoS purified fractions upon extensive
staining with either Coomassie blue or silver stain (Figure 4-lA and data flot shown).
The intensity of the purified polypeptide corresponded with the level of AP
endonuclease activity, that is, most of the activity was present in the 0.4 M NaC1
f . .fraction (Figures 4-lA, lane 4, and B). Increasing amount of the punfied polypeptide
present in the 0.4 M NaC1 fraction resulted in an increase production of the 20-mer
product, strongly suggesting that the purified protein contained AP endonuclease
activity (figure 4-1 C). This purified protein also cleaved acid treated plasmid DNA
containing a single AP site, indicating that the activity is not speciflcally acting on the
42-mer substrate (data flot shown). The protein was unable to nick native single
stranded or double-stranded DNA, suggesting that it lacks endonuclease activity (data
not shown). Moreover, the protein cannot cleave the 42-mer double-stranded
oligonucleotide containing the UG misrnatch, unless the uracil is removed consistent
with the notion that the purified protein fraction has associated AP endonuclease
activity (data not shown). In additional control experiments, we assessed the purified
protein fraction for the presence of enzymes that belong to the base excision DNA
repair pathway including AP lyase, DNA polymerase, and DNA ligase. However,
none of these enzymatic activities was displayed by the purified protein fraction,
indicating that the AP endonuclease activity is not associated with other base excision( repair proteins (data not shown).
10$
2+.Figure 4-1. Purification of a Mg -mdependent AP endonuclease enzyme.
(A) The eluted fractions from the final step of purification on a Mono $ column were
analyzed by an SDS-PAGE gel stained with Coomassie blue. (B) The eluted fractions
from A were assayed for AP endonuclease activity (see Materials and Methods). (C)
An increasing arnount the purified polypeptide was assayed for AP endonuclease
activity (lanes I to 5, 1, 5, 10, 25, and 50 ng, respectively). Purified endo IV (lane 6;
100 ng) was used as a positive control. The AP endonuclease assay was monitored by
autoradiography following resolution on a 10% polyacrylamide (19:1
acrylamide:bisacrylamide ratio)-7 M urea sequencing gel. Anows indicate positions
ofthe 42-mer substrate and the 20-mer product.
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Identification of GAPDH in the purified protein fraction
b determine the identity of the 37 kDa purified protein, the polypeptide hand
was excised and analyzed by mass spectrometry [209]. 0f 59 individual sequences
(MS/MS spectra) analyzed, ail showed 95 to 100% identity to the human GAPDH
enzyme. GAPDH was originally discovered as a glycolytic enzyme, which uses the
cofactor NAD+ to catalyze the conversion of glyceraldehyde-3-phosphate to 1,3-
diphosphoglycerate with the concomitant release of NADH in an oxidation-reduction
reaction [193]. To ascertain that our purified protein is indeed GAPDH, we tested for
its enzymatic activity by monitoring NADH formation via absorption at 340 nm
[1601. The purified protein displayed a comparable level of GAPDH activity when
compared to a commercial preparation ofliuman GAPDH (figure 4-2A).
Purïfied GAPUH exhibits no AP endonuclease activity
GAPDH bas been demonstrated to play a role in DNA repair, for example,
binding to specific DNA lesions [210]. To directly test if that our purified GAPDH
protein bas either an intrinsic or a tightly associated protein with AP endonuclease
activity, we inserted in-frame the cDNA encoding the entire human retina GAPDH
next to the glutathione S-transferase (GST) gene in the pGEX-4T-l bacterial
expression vector to produce the plasmid pGST-GAPDH. The pGST-GAPDH
plasmid was introduced into the E. cou strain BW528 (which lacks AP endonuclease
activity, see below) and the protein extracts derived from transformed bacteria were
passed onto a glutathione column to purify the GST-GAPDH fusion protein. The full
length GST-GAPDH (63 kDa) appeared to he the major polypeptide. although some
minor lower molecular weight species that could be degradation products were also
detected by Coornassie blue staining (figure 4-2B). Moreover, the GAPDH assay
revealed that the purified GST-GAPDH fusion protein exhibits a significant level of
activity as compared to the purified native untagged forrn of GAPDH (f igure 4-2A),
thus suggesting GST-GAPDH is functionally active.
G111
Figure 4-2. Purified polypeptide is the glycolytic enzyme GAPDH.
(A) Measurement ofthe GAPDH glycolytic activity from the commercial preparation
of human GAPDH (opened circles), the purified polypeptide (filled circles), and the
fusion proteins G$T-GAPDH (fihled squares), GST-GAPDH Cl 52G (opened
triangles), GST-GAPDH C 156G (filled triangles), and GST-GAPDH C247G (opened
squares) was done by spectrophotometric assay at 340 nm. (B) Expression and
purification of GST-GAPDH using E. cou. Total extracts derived from BW528 strain
carrying the pGST-GAPDH plasmid were purified on GST affinity columns and
analyzed on a SDS-PAGE gel stained with Coomassie blue. Lane 3 contained 200 ng
of the purified GST-GAPDH fusion protein. Molecular mass standards (kDa) are
shown in lane 1.
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We next examined if the GST-GAPDH fusion protein possessed the ability to
L
cleave the AP site substrate. No 20-mer products was observed with the GST
GAPDH fusion protein (see Figure 4-4 below), indicating that it lacks AP
endonuclease activity and free of contamination by AP endonucf cases. Furthermore,
sequence comparison of GAPDH with the two known families of AP endonucleases,
Endo IV and Exo III, yielded no signfficant similarity, thus exciuding the possibility
that GAPDH bears a nuclease motif (data flot shown).
On the basis of these above findings, we strongly believe that GAPDH does flot
contain an intrinsic AP endonuclease activity, and may instead be tightiy associated
with sucli an activity.
Interaction of GAPUH with APE1
To examine whether GAPDH is associated with an AP endonuclease activity,
we generated affinity chromatography columns of GST-GAPDH-Sepharose 4B or
GST-Sepharose 4B as described under Materials and Methods. The coiumns were
t
loaded with LF1 ccli extracts, washed and directly tested for AP endonuclease
activity. The GST-GAPDH colurnn retained an AP endonuclease activity. whereas in
contrast, no AP endonuclease activity was detected with the G$T column (data not
shown). Since the major AP endonuclease present in human lung fibroblasts is due to
APE1, we strongÏy suggest that this protein is likely interacting with GAPDH
resuiting in the observed associated AP endonuclease activity.
To analyze if the interaction between GAPDH and APEY is direct, we
prepared a Talon affinity colunrn consisting of ftinctionaiiy active N-terminal fis
tagged APEY and performed affinity chromatography assays (see Materiais and
Methods). Thus, purified GST-GAPDH was applied onto a HIS-APE1 column and
the binding analyzed by Western blotting using anti-GST antibody. As shown by
Figure 4-3A, GST-GAPDH did directiy bind to the HIS-APE1 column, but not to the
ernpty Talon column (lane 4 vs lane 3, fanes 5-10 are discussed below). In additional
control experirnents, the DNA repair protein PNKP (polynucleotide kinase 3’-
phosphatase) fused to GST did not bind to the HIS-APE1 column, suggesting that
t
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Figure 4-3. GAPDII interacts directly with APE 1.
(A) Equal amounts (200 ng) of purified G$T-PNKP (lanes 1 and 2), GST-GAPDH
(lanes 3 and 4), GST-GAPDH C152G (fanes 5 and 6), G$T-GAPDH C156G (fanes 7
and 8), and GST-GAPDH C 147G (lane 9 and 10) fusion protein were loaded onto
either empty TALON (lanes 1, 3, 5, 7, and 9) or HIS-APE1-conjugated TALON
columns (fanes 2, 4, 6, 8, and 10), followed by extensive washing and direct analysis
of the column matrix by Western blotting with an anti-GST antibody. Molecular
weight standards (kDa) are shown on the lefi. (B) Purified HIS-APE1 fusion protein
was loaded onto either GST-PNKP (lanel), GST (lane 2), or GST-GAPDH (lane 4)
column and assayed for binding. Bound HIS-APE1 fusion proteins were eluted and
analyzed by Western blotting with anti-HIS antibody (right panel). Inputs of HIS
APE1 (fane 3), GST (fane 5), and GST-GAPDH (fane 6) were also loaded. Molecular
weight standards (kDa) are shown in the middle. (C) Immunoprecipitation
experiment. Polyclonal anti-APEI antibodies speciflcally precipitated GAPDH from
HCTJ16 ceil extracts (lane 4). GAPDH was not immunoprecipitated in a mock
immunoprecipitation reaction (lane 3). 10% (150 tg) and 20% (300 tg) ofthe total
input are shown in lanes 1 and 2, respectively. Molecular weight standards (kDa) are
shown on the lefi. (D) AP endonuclease assay with commercial preparations of
GAPDH from pig (fanes 3-5; 20, 40, and 60 ng, respectively) and yeast (lanes 6-8;
20, 40, and 60 ng, respectively). Purified endo IV (lane 2; 100 ng) was used as a
positive control. Arrows indicate positions of the 42-mer substrate and the 20-mer
product.
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APE1 interacts specifically with GAPDH in vitro (Figure 4-3A, lane 2). To confirm
that GAPDH directly binds to APE1, a reverse affinity chromatography was
perfomed using purified HIS-APE1 and $epharose 4B columns containing either
GST-GAPDH, GST-PNKP, or GSI alone. Purified HIS-APE1 was then Ioaded
separately onto the three Sepharose 4B columns. Resuits revealed that HIS-APE1
associated with the GST-GAPDH column, but neither to the GST-PNKP nor the G$T
column, confirming that APE1 and GAPDH interact specifically in vitro (figure 4-
3B, lane 4 vs lanes 1-2).
To investigate whether GAPDH and APE1 may interact in vivo,
immunoprecipitation experiments were carried out. HCTÏ 16 ceil extracts were
immunoprecipitated using an anti-APE1 antibody and the presence of GAPDH in the
immunoprecipitates was analyzed by Western blotting, using anti-GAPDH
antibodies. As shown in figure 4-3C, endogenous APE1 and GAPDH
coimmunoprecipitated, suggesting that both proteins might be associated in the ceils.
Together these in vitro and in vivo resuits indicate that commercial
preparations of GAPDH are also likely to 5e associated with APEY AP endonuclease
activity. To test this assumption, we performed AP endonuclease assays using
commercial source of GAPDH derived from human, rabbit. chicken, pig, and yeast.
GAPDH from a mammalian source such as pig nicked the AP site substrate, but flot
from yeast which does flot possess APE1 protein (Figure 4-3D, lanes 3-5 vs lane 6-8).
In control experiments, the glycolytic enzymes pyruvate dehydrogenase and 6-
phosphofructokinase obtained from the same commercial source did not contain any
detectable level of AP endonuclease activity (data flot sliown).
Activation ofAP endonuclease actïvity ofAPEI by GAPUH
It is well documented that APE1 exists in the oxidized and reduced forms
[116] and that the reduced form is necessary to activate transcription factors including
p53, NF-KB, and c-Jun and c-fos, subunits of AP-1 [109,203,204]. Moreover, it bas
been shown that thioredoxin is required to activate APEY in order to potentiate AP-1
transcriptional activity [116]. As sucS, we explored the possibility if GAPDH could
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function to activate APE1 AP endonuclease activity. In this experiment, we first
L determined the minimal amount ofpurified HIS-APE1 that showed no detectable AP
endonuclease activity. Purified HIS-APE1 in the range of 0.1 to 2 ng showed no
measurable AP endonuclease activity (Figure 4-4, lane 3 showing 1 ng), while a
significant level of activity was observed with 10 ng of the protein (figure 4-4, lane
4). We next assessed if preincubating a fixed amount (1 ng) of HIS-APEI with
increasing amounts of GST-GAPDH would reveal any level of AP endonuclease
activity. As shown in Figure 4-4, the HIS-APE1 AP endonuclease activity was indeed
revealed by increasing arnounts of GST-GAPDH (lanes 13 to 16). In control
experiments, neither purified GST nor GST-PNKP activated the HTS-APE1 AP
endonuclease activity (lanes 9 to 12, and data flot shown). Since the purified GST
GAPDH from E. cou is free of contaminating AP endonuclease activity (Figure 4-4,
lanes 7 and 8, and also above), we suggest that GAPDH may play a role to reactivate
an inactive form of APE 1.
(. GAPDH functions to reduce the oxitlized form ofAPE1
Since APEÏ exists in the oxidized and reduced forms, which correspond to its
inactive and active state, respectively, we therefore assessed whether APEÏ redox
status is affected by GAPDH. Silver stain analysis under nonreducing conditions of
purified HIS-APE1 revealed a set ofheterogenous hands (figure 4-5A, lane 1). When
HIS-APE1 was incubated with an excess ofpurified GST-GAPDH, the heterogenous
bands of APE1 migrate as a single band (or monomer) and became more intensely
stained (Figure 4-5A, lane 4). This phenomenon was not observed when HIS-APE1
was incubated with either glutathione or purified GST (Figure 4-5A, lanes 2 and 3,
respectively). When the same experiment was performed with a reducing buffer
(Figure 4-5A, lanes 7-9), monomers of HIS-APEÏ were intensely stained by silver
nitrate independently of the presence of GST-GAPDH (figure 4-5A. lane 9).
Analysis of the purified protein under reducing conditions (Figure 4-5A, lane 6)
C
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Q Figure 4-4. GAPDII stimulates APEI AP endonuclease activity.Increasing concentrations: 1, 10, 25, and 50 ng, ofeither purified GST (lanes 9 -12)
or GST-GAPDH (Ianes 13-Ï 6) were added to 1 ng of purified HIS-APEI (lanes 9-
16). Purifled HIS-APE1 (1 and 10 ng, lanes 3 and 4, respectively), GST (1 and 50 ng,
lanes 5 and 6, respectively), and GST-GAPDH (1 and 50 ng, lanes 7 and 8,
respectiveÏy) were assayed alone in control experiments. Arrows indicate positions of
the 42-mer substrate and the 20-mer product.
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Figure 4-5. GAPDH stimulates APE1 AP endonuclease activity via a redox
reaction.
(A) GAPDH affects the redox state ofAPEÏ. Either glutathione (lanes 2 and 7), GST
(lanes 3 and 8), or GST-GAPDH (lanes 4 and 9) was incubated with HIS-APE1
(lanes 1-4 and 6-9) at 37°C for 30 min. Reactions were analyzed on SDS-PAGE gel
under non-reducing (lanes 1-5) or reducing conditions (lanes 6-9) and stained with
silver nitrate. The right anows indicate the positions of the reduced and oxidized
forms of HIS-APEÎ. The lefi arrows indicate the positions of the purified GST
GAPDH, HIS-APE1, and GST proteins. Molecular mass standards (kDa) are shown
on the lefi. (B) GAPDH stirnulates oxidized APE1 AP endonuclease activity in a
dose-dependent mamer. Chernically oxidized HIS-APEI (20 ng) was added to either
5, 20 and 50 ng ofpurified GST (lanes 10-12, respectively) or 5, 20, 50, and 100 ng
of purified GST-GAPDH (lanes 13-16, respectively); 1, 10, and 50 ng of purified
HIS-APEJ, lanes 3-5, respectively; 20 and 100 ng ofoxidized HIS-APE1, lanes 6 and
7, respectively; 50 ng of purified GST, lane 8; and 50 ng of GST-GAPDH, lane 9.
Purifled endo IV (lane 2; 100 ng) vas used as a positive control. Arrows indicate
positions ofthe 42-mer substrate and the 20-mer product.
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confirms previous data which showed that APE1 moves as a monomer under
reducing conditions [1161. Taken together, these resuits suggest that stimulation of
APEJ AP endonuclease activity resuits from a reduction reaction mediated by
GAPDU.
To ftirther test whether GAPDH can affect AP endonuclease activity of
oxidized APE1, we performed an AP endonuclease assay with chemically oxidized
purified HIS-APE1 (HIS-APE1od) and different amounts of purified GST-GAPDH.
As shown in Figure 4-5B, in the presence of 20 ng of HIS-APE10d, which does flot
show any detectable AP endonuclease activity (lane 6), GAPDH stimulated AP
endonuclease activity in a concentration-dependent fashion (lanes 13-16). Moreover,
reducing agents such as NAC (N-acetylcysteine). glutathione, and DTT
(dithiothrietiol), used at 1 and 5 mM concentrations, did not have a stimulatory effect
on HIS-APE10d AP endonuclease activity (data not shown). These results indicate
that GAPDH might perform a specific role regarding the reactivation of oxidized
APE1 AP endonuclease activity via a redox reaction.
C
Mutation of cysteine 152 and 156 of GAPDH to glycine affects die reactivation
the AP endonuclease activity
If indeed GAPDH serves as a redox factor for APE 1, we expect that it should
contain redox cysteines. Analysis of GAPDH amino acid sequence revealed that it
possesses two cysteine amino acid residues at positions Cys152 (C 152) and Cys156
(C156) (152CT1NC156) that showed similarities with the conserved redox center of
thioredoxin (32CGPC35). As such, we investigated whether the cysteine residues
Cl 52 and C 156 in GAPDH are important for the interaction and/or the reactivation of
oxidized APE1, we substituted these residues with glycine by site-directed
mutagenesis in the pGST-GAPDH plasmid. Another glycine substitution at cysteine
247 (C247) was done to serve as a control. The mutated and wild type plasmids were
transformed in E. cou and the corresponding fusjon proteins purified as described
under Materials and Methods. The mutated proteins migrated on gels at the same
position as wild type GST-GAPDH and were expressed with similar efficiency
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(Figure 4-3A), suggesting that mutations did flot induced major structural
deformation to trigger proteolysis. The mutant fusion proteins were thus as stable as
the wild type GST-GAPDH. However, conversion of C152 and C156 to glycine
reduced GAPDH activity by approxirnately 33%, when compared to either the C2470
or wild type protein (Figure 4-2A).
To test whether the cysteine to glycine substitution in GAPDH affects the
interaction with APE 1, we used the affinity chromatography approach to monitor for
retention of GAPDH and its variants. As shown in Figure 4-3A, ah GAPDH variants
bind to HIS-APE1 columns (lanes 6, 8, and 10), suggesting that glycine substitution
did not affect the ability of GAPDH to interact with APE1.
To address the contribution of C152 and C156 residues in the stimulation of
oxidized APE1 AP endonuclease activity, we used the purified mutated proteins in in
vitro AP endonuclease assays. The conversion of Cl 52 and Cl 56 to glycine abohished
the stimulation of HI$-APE10d (Figure 4-6, lanes 6-9 and 10-13). In contrast, amino
acid change at C247 did not affect the reactivation ofHIS-APE10d. Taken together,
these data strongly suggest that GAPDH utihizes Cl 52 and Cl 56 in the redox reaction
to reactivate HIS-APE 1 oxj•
Overexpression of GAPU11 enhances cellular resistance to MMS and 11202, but
notUVC
As our resuits indicate that GAPDH is able to modulate APEÏ activity in
vitro, we aimed to study whether overexpression of GAPDH affect cellular sensitivity
to DNA darnaging agents. Thus, we examined the response of DLD-1 celis that are
stably transfected with an expression vector harboring GFP-GAPDH or GFP (that
was used as a control) [211] to MMS, 11202, and UVC. MMS and 11202 are known to
induce APE 1 -repairable DNA lesions, whereas UVC produces DNA damage that are
repaired by the NER pathway. DLD-1 ceils overexpressing GAPDH displayed 2- to
3-fold increase in protection against MMS and H202 (Figure 4-7A, lefi and right
panel, respectively). In contrast, overexpression of GAPDH did not confer additional
C
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figure 4-6. Cysteine 152 and 156 residues of GAPDII are important to stimulate
APE1 AP endonuclease activity.
The following amounts of either GST-GAPDH (lanes 2-5), GST-GAPDH C152G
(lanes 6-9), GST-GAPDH C156G (lanes 10-13), or GST-GAPDH C247G (lanes 14-
17) was incubated with 20 ng ofpurified HIS-APE10d (lanes 1-17): 1, 10, 25, and 50
ng. Endo IV (lane 19) was used as a positive control. Arrows indicate positions ofthe
42-mer substrate and the 20-mer product.
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resistance to UVC in comparison to ceils transfected with the GfP control vector
(Figure 4-7A, center panel). Thus, the increase cellular resistance observed in DLD-1
ceils overexpressing GAPDH to MMS and I-1202 appears to reflect the stimulation of
APE AP endonuclease activity by GAPDH.
GAPPU function is necessary for protection against APE1-repairable UNA
damage
To further address the role of GAPDH in response to DNA damage, we took
advantage of siRNA technology to inhibit GAPDH function. HCTÏ 16 cells were
transfected with either the control or GAPDH siRNAs. The transfected celis were
then screened for suppression of GAPDH levels by Western blot analysis. As shown
in Figure 4-7B, the three ceil populations that were chosen exhibited >50% reduction
in GAPDH protein levels (lanes 2-4). The GAPDH knockdowns showed no apparent
differences in growlh rate as compared with their counterparts that have normal levels
of GAPDH (data not shown). Then, we exposed GAPDH knockdowns to various
concentrations of MMS, H202, and to increasing doses of UVC, following which we
perforrned celi viabiÏity assays. The resuits showed that suppression of GAPDH by
siRNA markedly sensitized HCTÎ16 ceils to MMS and JI202 (Figure 4-7C, lefi panel,
and data not shown). However, GAPDH silencing did not produce sensitization to
UVC, but interestingly provided partial resistance to UVC as compared to control
siRNA (Figure 4-7C, right panel).
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Figure 4-7. GAPDH plays an important ro]e in protecting celis against MMS
and 11202, but not UVC.
(A) The percentage of DLD-1 viable ceils overexpressing pGFP-GAPDH (filled
circles) or control pGfP (open circles) (as shown in the inset) afier treatment with
varying concentrations of MMS (lefi panel) and H202 (right panel), and increasing
doses of UVC (center panel). (B) Inhibition of GAPDH by siRNA. HCTÏI6 cells
were transfected by 75 nM of either siRNA against GAPDH (lanes 3 and 4) or control
siRNA (lanes 1 and 2). Western blotting was done to confirm the knockdown using
either anti-GAPDH (upper panel) or anti-APEY (middle panel) antibody with 15 and
30 jig of celi extracts (lanes 1-3 and 2-4, respectively). Ponceau red staining is shown
as a loading control (lower panel). (C) The percentage of survival of HCT116 ceils
transfected with GAPDH siRNA (open circles) or non-transfected (flhled circles) afier
treatment with various concentrations of MMS (lefi panel) and with various doses of
UVC (right panel).
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DISCUSSION
The human AP endonuclease APE1 plays a central role in the BER pathway
by performing various DNA repair functions, with the most important being its AP
endonuclease activity. However, uncontrolled cleavage by APEI could lead to
increased genomic instability, similarly to our previous findings which showed that
overexpression ofyeast AP endonuclease Apnl enhanced poly(GT) tract instability in
the mitochondrial genome [212]. Thus, the DNA repair functions of APE 1 must be
regulated to prevent undesired DNA cleavage. Posttranslational modification by
oxidationlreduction is emerging as a critical mechanism for the regulation of protein
activities, in particular for modulating the BER enzymes. Previously, Kelley and
Parson reported that the DNA repair fiinction ofAPE1 was modulated by a change in
the redox status of the protein [11$]. Under oxidizing condition, APE1 protein is
completely inhibited [11$]. More recently, Bravard et aï. demonstrated that the
activity of human DNA glycosylase OGG1, which initiates the BER process, is also
regulated in a redox-dependent manner [213]. They showed that an acute exposure to
cadium, a ubiquitious environmental pollutant that is classified as a human
carcinogen, caused nearly complete inactivation of OGG1 $-oxoG DNA glycosylase
activity, but which was reversed after the removaÏ of the heavy metal in human celis
[213]. Here. we provide strong evidence that GAPDH might contribute a redox role
to regulate the AP endonuclease activity of oxidized APE1.
GAPDH was identified by mass spectrometry analysis following our search
2+.for a protem exhibiting Mg -rndependent AP endonuclease in human celis. Our in
vitro enzymatic assays aÏlowed us to clearly establish that GAPDH lacks intrinsic AP
endonuclease activity, and thus it must be associated with the known AP
endonuclease, APEI. Indeed, GAPDH interact with APEI both in vitro ami in vivo as
demonstrated by affinity chromatography and immunoprecipitation experirnents,
respectively. We strongly believe that GAPDH binds to a minor form of APE 1 with a
different mobility pattern since we could flot detect any polypeptide bands besides
GAPDH by neither Coomassie blue nor silver staining as well as by mass
spectrometry. In addition, the Mg2-free buffers used during our purification
2+procedure can not susta;ned APE1 DNA repair activities as Mg plays a major role
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by promoting an activated (or open) DNA backbone conformation for DNA incision
by APE1 [214]. However, APE1 was shown to possess sorne incision activity for
ring-closed AP sites even in the presence of EDIA, a metal chelating agent [214]. Tt
remains to be investigated whether GAPDH stimulates APEY AP endonuclease
activity towards in vivo AP site substrates that are susceptible to Mg2tindependent
cleavage.
GAPDH is now recognized as a multifunctional protein which displays a
distinct membrane, cytosolic, and nuclear localization [215]. This latter cellular
location of GAPDH has been questionable until recently, when reports showed that
GAPDH possesses a CRMÏ-dependent nuclear export signal and that it is able to
translocate to the nucleus by binding to the nuclear localization signal-containing
protein, Siah 1 [211,216]. These studies support the several new nuclear functions of
GAPDH which have recently emerged. These includes the transcriptional regulation
of H2B gene expression [199]. the role of GAPDH in maintenance of telomere
structure [217], in membrane celi fusion [218], in the recognition of drug-induced
DNA lesions arising, e.g., from cancer chemotherapy [219], and in triggering
apoptosis [216,220].
Here, we clearly demonstrated that GAPDH stimulates the AP endonuclease
activity of oxidized APE 1, as measured by an in vitro AP endonuclease assay. This
stimulation of oxidized APE1 occurs perhaps through a redox reaction involving the
Cys 152 and Cys 156 residues of GAPDH. However, neither cysteine residue has been
shown to play a role in redox reaction, except for participating in the reduction of the
glyceraldehyde-3 -phosphate to produce 1,3 -diphosphoglycerate in the glycolytic
pathway [215]. The cysteines of GAPDH are separated by one additional amino acid
residue (152CTTNC156), as compared to the redox active cysteines of thioredoxin
(32CGPC35) [2211. Whether the cysteines of GAPDH are involved in a redox
reaction or catalyzed protein disuiphite isomerization of redox sensitive proteins
awaits further analysis. It is noteworthy that APE1 protein possesses seven cysteine
residues any number of which could be targets for regulation through redox
modification. In fact, Cys3lO of APE1 has been previously shown to be involved in
the redox control of the enzyme repair functions [118].
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The interaction of GAPDH with a key BER enzyme, APE1, is further
supported by a report which dernonstrated that GAPDH acts as a uracil DNA
glycosylase which initiates the BER pathway by removing uracil bases generated by
oxidative deamination of cytosine bases from the DNA [195]. Thus, GAPDH appears
to play a dual role in the BER process. On the one hand, GAPDH removes the uracil
to create an AP site and on the other, it stimulates APEÏ AP endonuclease activity
which wilI remove the AP sites. Since, OGG1 DNA glycosylase activity has been
demonstrated to be regulated through redox reaction [213], it is tempting to speculate
that GAPDH may serves a redox factor for several other BER proteins. GAPDH is
one of the most abundant cellular proteins, thus mammalian celis may have found an
efficient way to increase BER efficiency by utilizing an abundant protein to
regenerate the activities of oxidatively darnaged DNA repair proteins [2221.
The biological importance of GAPDH in stimulating APE1 activity was
suggested by ce! 1 survival assays performed following exposure to genotoxic agents.
Our resuits clearly demonstrated that overexpression of GAPDH protects DLD-1 ceils
( against MMS and 11202. which are known to induce APE 1 -repairable DNA lesions,
but flot to UVC. Consistent with these resuits, siRNA knockdown of GAPDH
sensitizes HCTII6 ceils to MMS, but not to UVC.
The overexpression of GAPDH in DLD-1 hurnan colon carcinoma ceil une
did not resuit in apoptosis as observed by other groups. The role of GAPDH in
apoptosis has been of great interest since this cellular process is believed to be the
major mechanism underlying the pathophysiology of a variety of neurodegenerative
diseases, including Huntington’s [223], Alzheimer’s [224], and Parldnson’s [225].
GAPDH binds to some disease-related proteins such as huntingtin, -amy1oid
precursor protein, atrophin, ataxin, and the andogren receptor [223,224,226]. The
precise molecular mechanism by which GAPDH exerts its proapoptotic effects
remains unknown, but it involves nuclear transiocation of GAPDH [215]. Moreover,
six isoforms of GAPDH has been reported in purified nuclei of cerebellar granule
celis and whose level increases afier cytosine arabinoside treatment which is known
to induce apoptosis in neuronal celis [198]. Interestingly, only the more acidic
C
134
G isoforms are rapidly translocated in the nucleus and could be the forms thatregenerate oxidized proteins to the reduced forms.
In conclusion, the state of our knowledge with respect to the functional
diversity of mammalian GAPDH and the underlying basic mechanisms which provide
for its multidirnensional nature is stili growing. Several areas appear promising
namely the protein interactions of GAPDH with disease proteins as weIl as BER
enzymes. 0f particular interest is to determine if there is a key cysteine arnino acid
residue that is regenerated from its oxidized to the reduced state by GAPDH.
oCHAPTER S
GENERAL DISCUSSION
o
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( DISCUSSION
Endogenous and exogenous reactive oxygen species (ROS) constantly cause
damage to the cellular DNA. The consequence of oxidative DNA damage is generally
undesirable, contributing to degenerative processes such as aging and cancer [1,2].
Oxidative DNA damage is an important source of apurinic/apyrimidinic (AP) sites
and base damaged, such as 8-oxo-7,8-dihydroguanine ($-oxo-dGuo) and thymine
glycol (Tg). AP sites can also resuit from spontaneous hydrolysis of the N-glycosylic
bond and the removal of damaged bases by DNA glycosylases in the course of the
base excision repair (BER) process [227]. It has been calculated that normal human
liver celis present a steady-state level of about 50 000 A? sites per genome [22$].
Thus, AP sites are considered to be one of the most frequent endogenous lesions in
DNA [20]. In addition to being abundant, AP sites can induce mutations, which are
mainly single base-pair substitutions, and cell death by blocking DNA replication and
transcription [1]. To counteract the deleterious action of AP sites, organisms have
evolved several DNA repair pathways, including BER which constitutes the chef
defense mechanism against AP sites and the NER, a backup pathway [21].
AP endonucleases of the exo III (e.g. E. cou exo III and human APE1) and
endo IV (E. cou endo IV and yeast Apnl) family are key enzymes in the BER
pathway [60]. These enzymes recognize, and cleave the A? sites on the 5’ side ofthe
DNA phosphodiester backbone to create a free 3’-OH end for DNA polymerase
synthesis. The pïvotal crystallographic studies performed on representative members
of the two A? endonuclease farnilies (i.e. bacteria exo III and endo IV, and human
APEI) have lead to a detailed compreliension of the relationship between the
structure and function of A? endonucleases [60].
Our report on the first structure/function analysis ofthe eukaryotic counterpart
of bacteria endo IV, yeast Apnl, lias also provided insights into how AP sites are
recognized and cleaved by AP endonucleases (Chapter 2) [177]. More importantly.
our study revealed that although AP endonucleases are related, they still can use
slightly different rnechanisms to process damaged DNA [177]. Indeed, we observed
that the Apnl E15$G and D192G mutants display different characteristics when
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compared to the corresponding endo IV E145G and D179G mutants. The Apnl
E15$G variant is able to bind DNA, but flot endo IV E145G mutant. Moreover, the
D192G variant ofApnl completely lacks DNA repair activity, whereas the activity of
endo IV D179G mutant is reduced 40-fold. To account for the disparity in the DNA
binding capacity, we propose, based on the crystal structure of bacteria endo IV, that
the Apnl E158 residue serves solely in the binding of the Zn2 ions required for
catalysis, while the endo IV E145 residue is involved in both DNA binding and
coordinating the trinuclear Zn cluster [177].
However, the difference in the enzymatic activity of the endo IV D 179G and
Apnl D 192G mutant can not be explained based on the endo IV crystal structure. The
endo IV D179 and Apnl D192 residues appear both to be involved in the stabilization
of the catalytic Zn cluster. Stili, glycine substitutions of these residues do not appear
to affect the Zn content of both mutant enzymes [149]. Moreover, it is unlikely that
the substrate specificity can account for the disparity in the enzyme activity of the
endo IV and Apnl variants, as kinetics studies demonstrated that both enzymes
cleave various susbstrates, sucS as AP sites, THf, 5,6-dihydropyrimidines (DHU and
DHT), and Œ-anomeric 2’-deoxynucleosides (adN) with simHar efficiencies
[229.230]. On the other hand, the presence of an additional bipartite nuclear
localization signal at the C-terminus of Apnl may cause the protein to fold
differently, which miglit resuit in a changed conformation of the active site pocket
[$1,231]. Likewise, it would 5e certainly very insightful to compare the crystal
structures of the endo IV D179G and the apnl D192G mutant proteins in order to
determine whether any changes in active site structure occur as a result of these
mutations and whether the NLS of Apnl affects its protein conformation. In addition,
these structural studies should allow for a comprehensible interpretation of the
observed differences between the endo IV D179G and the Apnl D192G mutant
proteins in terms of catalytic efficiencies.
The importance of AP endonucleases lias been established by the fact that AP
endonuclease-deficiency leads to cellular hypersensitivity to certain genotoxic agents
and to genomic instability and mutations [94]. Guillet and Boiteux demonstrated that
( the simultaneous inactivation of two AP endonucleases (Apnl and Apn2) and of the
138
nuclease RadI-RadlO causes ceil death in $accharomyces cerevisiae, because ofthe
inablity of the apn]Aapn2AradlA triple mutant to repair endogenous AP sites and
related 3’-blocked single strand breaks [94]. In mammalian ceils, knockout of the
major AP endonuclease APE1 causes embryonic lethality, whereas APEÏ knockdown
induces inhibition of celi proliferation and activation of apoptosis which was
conelated with accumulation of AP sites [102,103]. Together, these studies strongly
suggest that the burden of AP sites is flot compatible with life in absence of DNA
repair.
AP endonucleases play a vital role by acting on AP sites that arise either
spontaneously or from the removal of damaged bases by DNA glycosylases. AP
endonuclease can also recognize modified bases independently of DNA glycosylases
and incise the damaged DNA to generate a 3’-OH group and a 5’-phosphate [84].
Moreover, Simonelli et aï. provided strong evidence that AP site-related lesions, such
as 3’- or 5’-blocked single strand breaks [e.g. 3’-Œ13-unsaturated aldehyde or 5’-
deoxyribose-5-phosphate (5’-dRp), respectively], are mutagenic and possibly more
toxic than AP sites thernselves [232]. Thus, one can assume that eukaryotic ceils
require a control repair by AP endonucleases in order to prevent the accumulation of
mutagenic intermediates.
Our recent study (Chapter 3) supports the existing evidence that AP
endonucleases are responsible for generating mutagenic intermediates [212]. In fact,
we demonstrated that overexpression of Apnl in an oggiA strain increased
mitochondrial poly(GT) tract instability in yeast cells, which was however
counteracted by Oggi DNA glycosylase overexpression. Consistent with our
observation, Padnis et al. showed that Ntgl DNA glycosylase-deficient yeast ceils
overexpressing Apn 1 exhibïted an increased ftequency of mitochondrial mutations,
which could be suppressed by deletion of Apnl [233]. Likewise, Doudican et aï.
demonstrated that oxidative DNA damage causes mtDNA instability in
Saccharomyces cerevisiae and that the mitochondrial helicase, Pifi, and Ntgl
cooperate to preserve mitochondrial genomic stability [234].
Considering the mutagenic potential of AP sites, our results strongly suggest
( that Oggi competes for binding to AP sites and protect a fraction ofthe lesions from
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spurious cleavage by the uncontrolled action of the overexpressed Apnl. One could
also consider the possibility that the repair of AP sites mediated by Oggi follows a
pathway that is less mutagenic than the pathway that is initiated by Apnl operating at
8-oxo-dGuo lesions. To date, no reports favor this hypothesis. On the contrary, a
recent report by Ischenko et al. found Apnl to be involved in an Oggi-independent
DNA repair pathway for $-oxo-dGuo residues, in addition to the BER pathway. The
authors revealed that this alternative repair requires the 3’-5’-exonuclease activity of
Apnl, which they showed to be as efficient as its AP endonuclease activity [86].
Notably, during our structure-function analysis ofApnl (Chapter 2) we also observed
that Apnl displays the ability to remove additional nucleotides in a 3’ to 5’ direction
following cleavage of an AP site [177]. However, the elucidation of the biological
significance of this 3’-S’-exonuclease activity was beyond the scope of our study.
Together, our findings further support the idea that uncontrolled ApnI activity
generates excessive DNA strand breaks, which are cytotoxic DNA repair
intermediates as they could induce DNA double strand breaks.
In a context, where proteins involved in DNA repair and replication co-exist
in the vicinity of DNA damage, the cell may preferably chose to protect AP sites from
further cleavage by an AP endonuclease. In agreement with this hypothesis, we
showed that AFN] deletion leads to a 2-fold decreased in the rate of poly(GT) tract
instablity in oggiA ceils (Chapter 3) [212]. We propose that Oggi competes with
Apnl for binding to AP sites such that these mutagenic lesions are protected from
undesirable repair. Indeed, it xvas previously estimated that human homolog of yeast
Oggl (hOGG1) is tightly bound to an AP site with the calculated half-life of the
complex being greater that 2 h [119,184]. Thus, to further support the fiinctional
interaction between Oggi and Apnl, the binding affinity of Oggl and ApnÏ for AP
sites needs to be clearly assessed. Using surface plasmon resonance (SPR) as
described by Hedge et al., we could propose to monitor in real time the interaction
between either Oggi or Apnl and DNA substrate containing an AP site [235]. The
sensorgrams generated by the SPR analysis can provide information on the binding
affinity of the protein for the DNA substrate. With this approach, Hedge et aï. found
C that hOGG1 has a higher affinity for AP sites than APE1 [235]. As such, we predict
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simiÏar behavior for yeast Oggi and Apnl. In addition, competition binding assays
with various damaged DNA substrates, including AP site-containing oligonucleotides
could also be performed to compare the binding affinities and specificities of Oggi
and Apnl.
Moreover, using an irmovative covalent trapping strategy, which consists of
inducing a disulfide crosslink between a protein and DNA to prevent the dissociation
ofthe protein-DNA interaction, Banerjee et al. established that hOGGÏ is capable of
discriminating G from 8-oxo-dGuo due to the presence of two distinct pockets, the G
specific pocket and the 8-oxo-dGuo recognition pocket, respectively [236]. The
unique structure of hOGG1 allows access to the normal G base to the G-specific
pocket and exciuding it completely from the subsequent binding to the 8-oxo-dGuo
pocket. This active site ofhOGGl only binds to DNA where it cncounters 8-oxodGuo
lesions [236]. Following cleavage of 8-oxo-dGuo, hOGG1 is likely to use its refined
structure to bind very tightly to the AP site repair intenriediate and protect it from
uncontrolled cleavage by the AP endonuclease APE1. The disulfide trapping strategy
could ccrtainly be used to test whether AP sites can be ‘trapped’ in the active site
pocket of yeast Oggl [236].
Interestingly, we demonstrated that anaerobic growth conditions prevented
destabilization of mitochondrial poly(GT) tract, suggesting that oxidative DNA
damages, particularly, 8-oxo-dGuo, are most Iikely the cause of poly(GT) tract
instability. However, we were unsuccessful at detecting a significant increase in the
levels of 8-oxo-dGuo lesions in the mtDNA derived from the ogg]zl mutant, as
compared to the parent strain. In fact, the analysis by HPLC of mitochondrial DNA
revealed a comparable level of 2-oxo-dGuo in the ogg]zI mutant (198 ± 12
lesions/106 G) and the parent (184 ± 10 lesions/106 G). In general, the assessernents
ofthe precise amounts of $-oxo-dGuo lesions in both nuclear and mitochondrial DNA
can be a challenging task due to the formation of artifacts by oxidation of dGuo
during sample preparation [237]. b circumvent this problem, Brink et aï. developed
a highly sensitive quantitative method consisting of on-une sample preparation by
HPLC coÏumn switching combined with tandem mass spectrometry (ESI-MS/MS)Ç [238]. This technique may prove to be a useful tool to study the biological importance
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of DNA repair proteins in the removal of both endogenous and exogenous DNA
damage.
Besides the BER pathway, mismatch repair (MMR) is the only pathway
reported to play an important role in the maintenance ofthe poly(GT) tract stability as
well as in the repair of oxidative damage in mtDNA [170,239]. The M$H] gene
encodes for the yeast homologue of the bacterial MMR protein MutS, which
possesses a critical function in mtDNA stability [170]. One study reported that the
high ftequency of mitochondrial mutations in an ogg]A mutant was significantly
suppressed by overexpresssion ofthe MSHJ gene [239]. Thus, it would be interesting
to conflnn this observation by overproducing Mshl in our oggiA mutant. Ahhough
the detailed mechanism by which Mshl prevents genornic instability remains to be
elucidated, Chang et aï. recently provided evidence that APE1 increased
microsatellite instability (M$I) by decreasing the levels of MSH6 protein. which is a
key player in the MMR pathway [240]. This suggested mechanisrn could also be
linked to the mitochondrial poly(GT) tract instability observed in our yeast strains
overexpressing Apnl since it was previously reported that Msh6 participates in the
removal of $-oxo-dGuo lesions through the mismatch repair pathway [2411 Thus, it
remains to be investigated whether the poly(GT) tract instability is caused by yeast
Apnl -mediated reduction of Msh6 expression in the mitochondria.
In BER, the enzymatic mechanism of the incision step accomplished by AP
endonucleases is well understood. However, knowledge of the molecular mechanisms
responsible for the regulation of the AP endonuclease activity is stiil scanty. This
situation is ftirther complicated by the multifunctional nature of mammalian AP
endonucleases. Indeed. APE 1 is not only responsible for repair of AP sites, but it also
plays a crucial role as a redox factor (thtis the acronym Ref-1) that maintains
important transcription factors (e.g. AP-1, Nf-icB, and p53) in an active reduced
state. These two activities of APE1/Ref-1 are encoded by two distinct functionally
independent protein domains: the non-conserved N-terminal domain is required for
the redox activity, whereas the conserved C-terminal domain contains the DNA repair
activity [112]. Thus, for a coordinated and proper ftinctioning of APEÎ/Ref-1 in the
( cellular context, it is necessary that its diverse functions are well regulated.
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Previously, the studies on the regulation of APE1/Ref-1 ftinctions mainly
focused on the gene expression and subcellular localization of the protein. The reports
showed that APE1/Ref-1 is a ubiquitous protein whose expression can be induced at
the transcriptional level by alleviating APE1!Ref-1 repression on its own promoter
activity [111]. While most studies have localized APEÎ/Ref-1 in the nucleus, it has
been reported that APE 1 /Ref- 1 is also present in the cytoplasm, mitochondria, and the
endoplasmic reticulum [111]. More recent studies have shifled their focus towards
other aspects of APE1/Ref-1 regulation, namely, protein-protein interactions and
posttranslational modifications [115]. Evidence from reconstituted systems and ce!!
bio!ogy suggests that APE1/Ref-1 activities are regulated by both physical and
functional interactions with BER enzymes and proteins participating in other
biological processes, such as DNA transcription and replication. Moreover, recent
data have emerged showing that APE1/Ref-1 is modified posttrans!ationa!ly by
phosphorylation, acetylation, and redox modification [115]. Importantly, these three
kinds ofposttranslationa! modifications were reported to affect APEÏ/Ref-1 activities.
Our study in Chapter 4 supports the notion that APE1/Ref-1 activities are
modulated via redox modification. We provided strong evidence that GAPDH, a wel!
established glycolytic enzyme, reduces APE1/Ref-1 through direct complex
formation. The redox reaction involves Cys152 and Cys156 in the putative redox
center of GAPDH, and although the target residues on APEI/Ref-l were not
determined, one residue is likely to be Cys3 10. This residue, which is immediately
adjacent to the crucial His309 residue in the DNA repair active site, was previously
found to be involved in the redox contro! ofDNA repair ftmction [118]. Functional!y,
the interaction of APE1/Ref-1 and GAPDH stimulates the AP endonuclease activity
of oxidized APE/Ref-1. As the DNA glycosylase activity of OGG1 was recently
demonstrated to be complete!y inhibited under oxidizing conditions, it is tempting to
speculate that GAPDH may serve as a genera! redox factor for other BER enzymes
[213]. Thus, mammalian cells may have found an efficient way to increased BER
efficiency by utilizing GAPDH, one of the most abundant cellular proteins, to
reactivate oxidatively damaged DNA repair enzymes. Thus, future studies may reveal
other biologicalïy relevant protein interactions ofGAPDH with BER enzymes.
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The mere association of GAPDH with the DNA repair enzyme APE1!Ref-1
implicates that the glycolytic enzyme is also a nuclear protein, although it does flot
contain a NLS like APE1/Ref-1 [242]. Recent studies demonstrated that GAPDH
nuclear localization is governed by both nuclear export and import, which are
mediated by its CRMÎ-dependent nuclear export signal and its binding to the NLS of
Siahi (seven in absentia homolog 1), a ubiquitin-E3 ligase, respectively [211,216].
furthermore, GAPDH was shown to transiocate from the cytoplasm to the nucleus
following various oxidative stresses such as treatment with H202, FeCN, and 1-
methyÏ-4-phenylpyridinium (MPPj [200]. The importance of GAPDH nuclear
transiocation is becoming more apparent as new nuclear functions for the enzyme
emerge. These include the transcriptional regulation of histone H2B gene expression,
the maintenance of telomere structure, the induction of apoptosis, and the binding of
incorrect nucleotides in DNA arising from cancer chemotherapy [242]. The role of
GAPDH in DNA repair was initially reported by Baxi and Vishwanata who
demonstrated that the enzyme bas uracil DNA glycosylase activity [194]. More
recently, Krynetski et al. showed that GAPDH is part of protein complex, distinct
ftorn MMR, that binds to DNA containing thiopurines, such as mercaptopurine [202].
The celi survival assays that we performed following treatment of two human
colon carcinoma ceil lines with various genotoxic agents clearly demonstrated the
importance of GAPDH in the protection against genomic threats. Our data clearly
showed that DLD-1 cells overexpressing GAPDH have an increased survival rate
following exposure to MMS and F1202, two DNA damaging agents known to induce
APE1-repairable lesions, as compared to ceils with basal levels of GAPDH.
Moreover, knockdown of GAPDH causes HCT 116 ceils to be sensitive to MMS.
flowever, neither overexpression nor GAPDH knockdown altered the sensitivity of
the celis to UVC (254 nm) ii-radiation. Although these resuits strongly suggest that
GAPDH actively participate in BER by stimulating APE1/Ref-1 activity, additional
in vivo experiments are needed to support this hypothesis. First, we can monitor the
AP endonuclease activity of total ccli extracts derived from cefls that either
overexpress GAPDH or that are knockdown for GAPDH, following exposure to the
C various genotoxic agents. According to our assumption, celi extracts
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overexpressed GAPDH should display higher AP endonuclease activity than celi
extracts containing endogenous levels of GAPDH, whereas celi extracts with reduced
amount of GAPDH should exhibit decreased AP endonuclease activity, as compared
to the control celi extracts. In the case of GAPDH lmockdown, we also need to verify
that the decreased A? endonuclease activity is flot resulting from a reduction in
APE1/Ref-1 protein levels. Second, we can compare the levels of total AP site
damage in chromosomal DNA of GAPDH-deficient and control HCT1 16 celis. Based
on our hypothesis, knockdown of GAPDH should contain higher leveÏs of AP sites
than control ceils.
Our study attributes a novel nuclear role to GAPDH as a redox factor for
APE1/Ref-1 enzyme (manuscript in preparation). More importantly, this study has
contributed to the understanding the redox modification as an important regulatory
switch between the DNA repair and redox function of Apel/Ref-l. Previously,
several groups have demonstrated that thioredoxin (TRX), a dithiol-reducing enzyme,
reduces APEY/Ref-1 to potentiate the DNA binding of transcription factors AP-1 and
p53 mediated by APE1/Ref-l [116,117]. Although the specific residues ofAPEI/Ref
I involved in the interaction with TRX are flot known, they may include Cys65 and
Cys93 as they have been shown to be redox-sensitive [116,117]. On the other hand,
Kelley and Parsons demonstrated that the DNA repair activity of APEÏ/Ref-1 is also
redox-regulated with the specific involvement of Cys3 10 [118]. Together, these
observations suggest that redox modification by TRX and GAPDH, two abundant
cellular proteins, of different sites in APEÎ/Ref-1 provides a flexible and powerful
means for fine-switching between the different functions of APE 1 /Ref- 1.
Conclu ding remarks
AP endonucleases appear to be crucial enzymes of BER. Indeed, unrepaired
AP sites can resuit in a block to DNA replication and in cytotoxicity, mutations, as
well as genomic instabiÏity. The biological importance of AP endonucleases is
underscored by the findings that knockout of APE1/Ref-1 in mice cause embryonic
lethality as well as by the Yack of stable APE1/Ref-1 cell unes. Until the recent report
C by fung and Demple (2005), it was unclear whether the lethality in
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knockout mice was due to the Ioss of the DNA repair ftinction or the redox activity of
APE1/Ref-1 [103]. In fact, these authors clearly showed that the AP endonuclease
activity is essential for cellular viability by using RNAi [103]. However, their resuits
do flot completely rule out the possible relevance of APE1/Ref-1 redox ftinction in
the maintenance of cellular viability. Stiil, our group and others have shown that
overexpression of AP endonucleases in either yeast or human ceils is not clearly
protective against cytotoxic and mutagenic lesions [212] [233]. In sorne cancers,
including ovarian, cervical and prostate cancer, increased levels of APEÏ/Ref-1 has
been observed which strongly coi-relates with enhanced resistance to radiotherapy and
chemotherapy [1111. These features make APE1/Ref-1 an attractive target for
anticancer dmg development. Furthermore, growing evidence for posttranslational
modification of APEI/Ref-l, including the one provided by our group, which
demonstrated that APE1/Ref-l AP endonuclease activity is regulated through a
GAPDH-dependent redox mechanism, confirrn a future investigative direction toward
a better comprehension of the role of APEY/Ref-1 in cancer. More importantly, the
challenge will be to integrate these findings in a biological context considering the
many proteins interactions involving APE 1 /Ref- Ï. These future studies will certainly
provide valuable insights for exploiting APE1/Ref-1 as a therapeutic target for several
pathologies, including cancer.
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